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ABSTRACT
DECODING THE MYSTERY OF ANTIBIOTIC PERSISTENCE
TAHMINA HOSSAIN
2022
This work combines microbiology, molecular biology, Next-Generation
Sequencing and system biology approaches to explore the mechanism of antibiotic
persistence: a multi-drug tolerant, non-dividing, and metabolically altered state present in
a subpopulation of cells due to phenotypic diversity rather than genetic variation (i.e.
mutations). Persister can survive lethal antibiotic state and resuscitate after the treatment
period is over. They are considered as the major contributing factor behind recurring
infections. They also have a high mutation rate, which increases the chances of bacteria
gaining antibiotic resistance. The formation of this phenotypic variant (persister) threatens
the therapeutic effectiveness of antibiotics and understanding how bacteria form these
heterogenic populations is critical for the development of new therapies.
The molecular mechanisms underlying persistence are varied and debated in the
literature. To probe this phenomena, I have explored three fundamental questions in this
study related to antibiotic persistence, 1) when do persister cells form, do they form in
response to the stress or are some cells prepared for stress (Chapter 2); 2) how do they go
into this metabolically altered state and maintain this state for long-term antibiotic
treatment (Chapter 3); 3) Is persistence an essential mechanism for bacteria and if so, does
a minimal cell form persisters (Chapter 4)?
There is much controversy in the literature when do these phenotypic variants
(persister) form. To understand this, I have taken a novel approach to explore bacterial
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heterogeneity using a powerful fluctuation test (FT) framework to infer transient cell states
that arise via reversible and non-genetic mechanisms to find hidden features of bacterial
persistence. The FT was first pioneered ~80 years ago when Luria & Delbrück
demonstrated that genetic mutations arise randomly in the absence of selection but not in
response to the selection. They were studying phage (bacterial virus) infection. At the time
of their work, it was debated whether mutations leading to resistance were directly induced
by the virus (Lamarckian theory), or if they arose randomly in the population before viral
infection (Darwinian theory). Their result showed genetic mutations arise randomly in the
absence of selection, validating the Darwinian theory of evolution and led to a Nobel Prize
in 1969. Our bacterial persister work is quite similar. Instead of studying mutations, we are
exploring the existence of primed cells (a heterogeneously distinct subpopulation) before
treatment that allow for long-term survival after treatment. Using the FT, we tested the
variation between clonal populations that originated from an identical clone and showed
that a subset of the population has an epigenetic "memory" that primes cells for persistence.
We support our results with experimental benchwork and mathematical models. I am the
first to definitively demonstrate that some cells are prepared in the population through a
stochastic mechanism that enters into persistence in response to stress. Our work highly
suggests that phenotypic heterogeneity is not entirely a random event resulting from
stochastic noise in gene expression. Instead, it can develop from a rare, transiently inherited
gene expression event.
Another most argued topic in persister research field is whether persister cells
transcribe during this non-dividing state in response to stress. To understand this, we isolate
RNA from persister subpopulation at different time-points and compare the persister
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transcriptome profile with before antibiotic treated culture. Our analysis of RNAsequencing data demonstrates that persisters actively transcribe and translate proteins and
they use multiple regulatory pathways to enter and maintain this altered state during
antibiotic treatment. From our transcriptome analysis, we have selected seven
uncharacterized genes which upregulated in persister cell and observed their effect on
persister survival by overexpressing or making knockouts of those genes. When we
overexpressed the hypothetical genes, most of them cause the growth defect and some of
them put the cells into sleepy state for several hours. Our knockout mutants decrease the
persister level dramatically by ~4-6 fold and ~10-15 fold at 3 h and 6h of Amp treatment,
respectively. However, at 24 h, it showed no significant difference in survival from wild
type which again showed that the persister transcriptome adjusts its expression profile over
time. This result demonstrated that persisters alter their transcriptome to maintain their
survival over the long-term antibiotic treatment. This research is particularly important,
because researchers in persister field still argued over this and often cited dormancy is the
primary method of persister survival.
Another exciting study I have done where we used a minimal cell Mycoplasma
mycoides JCVI-syn3B, contains only 491 genes and most of them are essential genes. We
demonstrated that this minimal cell persists against multiple antibiotics although it contains
a few already identified persister-related genes, whereas lacking many systems previously
linked to persistence (e.g. ribosome hibernation genes). We also found that Syn3B evolves
antibiotic resistance to different types of antibiotics expeditiously.
Overall, in this study I explored the regulatory mechanisms that allow persisters to
survive long-term antibiotic treatments. This work will impact our fundamental knowledge
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about antibiotic survival and set the groundwork for developing more effective therapeutics
for recurrent bacterial infections.

1
1. INTRODUCTION
1.1. Background
All bacteria lead their lives in extreme environment and must cope with stress by
maintaing a altered metabolic state (widely known as persistence state). In stable
environment, bacteria prepare for stress before it hits by maintaing phenotypic
heterogeneity within a population (Nathalie Q Balaban, Jack Merrin, Remy Chait, Lukasz
Kowalik, & Stanislas Leibler, 2004; Engl, 2019). Persistence (a multi-drug tolerant, nondiving state) is a bet-hedging strategy that all free-living bacteria utilize to endure stress
(Nathalie Q Balaban et al., 2019). Persisters have been studied for ~80 years (Lewis, 2010),
yet it is unclear and debated how bacteria enter persistence, survive antibiotics as persisters,
and exit persistence once antibiotics are removed. Though persisters are described as
dormant related to growth, they renders an active response against antibiotics (Heather S
Deter, Tahmina Hossain, & Nicholas C Butzin, 2021; Sulaiman & Lam, 2020). Multiple
mechanisms may allow for persistence, confounding our understanding even further.
1.2. Distinction among short-term tolerance, persistence and resistance.
The lack of specificity in the literature between short-term tolerant and persisters
has complicated the debate over genes essential to antibiotic survival. Different research
groups had their own definition of short-term tolerance and persistence, and the terms were
often used interchangeably, leading to confusion in the literature. A consensus statement
released after a discussion panel with 121 researchers defined antibiotic persistence as a
tolerant subpopulation of cells that result in a distinct phase of population decay (N. Q.
Balaban et al., 2019). Though this definition has support, it does not encompass all the
nuances of antibiotic survival. Therefore, we use population decay rates to differentiate
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between antibiotic short-term tolerant cells (dies quickly) and persisters (survives longer)
in this work (Fig. 1). Short-term tolerant cell dies quickly (first phase) than persisters which
survives long-term antibiotic treatment (second phase). Although both antibiotic resistance
and persistence make antibiotic treatment ineffective, but the distinction between them is
resistance arises from genetic changes and resistant bacteria can grow in presence of
antibiotics (Durao, Balbontin, & Gordo, 2018), while persistence arise from phenotypic
changes which let the bacteria survive in lethal stress through maintaining a non-growing
state.

Figure 1. A model of population decay
during antibiotic stress.
Short-term tolerant and slow growing cells die
quicker than the persisters.

1.3. Importance of persisters in public health.
Persister subpopulation exhibits long-term survival during antibiotic treatment and
make the antibiotic treatment ineffective (Nathalie Q. Balaban et al., 2019; Heather S
Deter, Abualrahi, et al., 2019; Pontes & Groisman, 2019; Van den Bergh et al., 2016).
However, after antibiotic therapy stops, surviving cells can revive and give rise to a new
progeny; the new progeny can be genetically identical to the original susceptible kin. This
process plays a pivotal role in recurring infections (D. Wilmaerts, Windels, Verstraeten, &
Michiels, 2019). For example, relapsed urinary tract infections commonly occur in 30% of
patients within four months of the infection (Ayrapetyan, Williams, & Oliver, 2018). The
same isolate found in the primary infections caused most of these recurrent infections
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(Bingen et al., 1992; Russo, Stapleton, Wenderoth, Hooton, & Stamm, 1995). Recurrent
antibiotic treatments can increase antibiotic persistence, which eventually leads to
antibiotic resistance (Levin-Reisman et al., 2017; Van den Bergh et al., 2016; Windels et
al., 2019) (Fig. 2).

Figure 2. Persistence permits antibiotic resistance.
Persisters survive antibiotic treatment, reestablish the population when antibiotics are
removed, and increase the odds of gaining resistance.

Antibiotic resistance is impacting both human healthcare (Martinez & Baquero,
2014; Pires, de Kraker, Tartari, Abbas, & Pittet, 2017) and livestock production (Wernicki,
Nowaczek, & Urban-Chmiel, 2017). For example, antibiotic-resistant microbes caused 2.8
million infections and 35,000 deaths in the US alone in 2019 ("Antibiotic resistance threats
in the United States, 2019," 2019). It is projected that by 2050 global deaths from
antibiotic-resistant microbes will be ~100M/year (Huemer, Mairpady Shambat, Brugger,
& Zinkernagel, 2020) unless new technologies are developed to combat them. Salmonella
infections in the US alone lead to annual economic losses of about 1.3 billion dollars, and
in 2005 the poultry industry lost approximately 1,000,000 birds mainly due to bacterial
infections (Wernicki et al., 2017). The US Department of Agriculture Economic Research
Service estimates that foodborne illnesses annually cost over $15 billion (Economic
Research Service (ERS), 2018). The common approach to combat resistance is to prolong
the antibiotic treatment, limit (ration) antibiotics, use multiple antibiotics and high doses
to kill resilient pathogens, or develop new antibiotics. However, these approaches have had
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limited success. Prolonged use of lethal antibiotic concentrations kills beneficial bacteria,
leading to chronic illness (Blaser, 2011; Y. J. Zhang et al., 2015). Antibiotics are then
released into nature (from humans/animals, or other sources (Larsson & Flach, 2021)),
leading to resistant mutants.
Not only do persisters increase the likelihood that a bacterial community develops
resistance, but they also increase the risk of infection reestablishment, particularly in
biofilms (N. R. Cohen, M. A. Lobritz, & J. J. Collins, 2013), which are often comprised of
~1% persisters (Shah et al., 2006; T. K. Wood, Knabel, & Kwan, 2013). The surviving
persister cells also impede medical equipment sterilization because they can reestablish the
biofilm (Lewis, 2010; Rowe, Conlon, Keren, & Lewis, 2016).
1.4. Goals and objectives
Antibiotics revolutionized the treatments of infectious diseases. The discovery of
penicillin in 1941 was one of the most momentous medical advances of the 20th century
and led to a new age of human medicine. Subsequently, several antibiotics were quickly
developed. But, over the time antibiotic overuse become a prevalent public health concern
because it simultaneously drives microbial evolution and resistance (Baker, Thomson,
Weill, & Holt, 2018; N. R. Cohen et al., 2013; Durao et al., 2018; Furusawa, Horinouchi,
& Maeda, 2018). Thus, in the intervening decades, the race to develop new antibiotics is
slowly being outpaced by the spread of resistance (Durand, Raoult, & Dubourg, 2018). As
this trend continues, the battle to develop new antibiotics became an urgent need (Durand
et al., 2018). But, developing new antibiotics is quite challenging because bacteria quickly
gain resistance nearly all antibiotic available on market; there has been a decline of new
antibiotics coming to market for the last 20-30 years (Ventola, 2015; Y. J. Zhang et al.,
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2015). In this study, I particularly focuses on persisters because they mutate at a high rate
(Windels et al., 2019) and are a major driving force of antibiotic resistance (N. R. Cohen
et al., 2013; Windels et al., 2019). To hinder antibiotic resistance, it is crucial to understand
the mechanism of persister cells.

The main goals of this study are1. To understand when do these phenotypic variants (persisters) form within a
population by using Luria-Delbruck Fluctuation test.
2. To understand the regulatory mechanism of persisters by using transcriptomic
analysis.
3. To study persisters in a minimal cell (containing only essential genes) by using
synthetically developed minimal cell, Mycoplasma mycoides JCVI-Syn3B.
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2. ESCHERICHIA COLI CELLS ARE PRIMED FOR SURVIVAL BEFORE LETHAL
ANTIBIOTIC STRESS
2.1. Summary
Non-genetic factors can cause significant fluctuations in gene expression levels.
Regardless of growing in a stable environment, this fluctuation leads to cell-to-cell
variability in an isogenic population. This phenotypic heterogeneity allows a tiny subset of
bacterial cells in a population, referred to as persister cells, to tolerate long-term lethal
antibiotic effects by entering into a non-dividing, metabolically altered state. One
fundamental question is whether this heterogeneous persister population is due to a preexisting genetic mutation or a result of a transiently-primed reversible cell state. To explore
this, we tested clonal populations starting from a single cell using a modified Luria–
Delbrück fluctuation test. Through we kept the conditions the same, the diversity in
persistence level among clones was relatively consistent: varying from ~60-100 and ~4070 fold for ampicillin (Amp) and apramycin (Apr), respectively. Then we divided and
diluted each clone to observe whether the same clone had comparable persister levels for
more than one generation. Replicates had similar persister levels even when clones were
divided, diluted by 1:20, and allowed to grow for ~5 generations. This result explicitly
shows a cellular memory passed on for generations and eventually lost when cells are
diluted to 1:100 and regrown (>7 generations). Our result demonstrates 1) the existence of
a small population prepared for stress ("primed cells") resulting in higher persister
numbers, 2) the primed memory state is reproducible and transient, passed down for
generations but eventually lost, and 3) a heterogeneous persister population is a result of a
transiently-primed reversible cell state and not due to a pre-existing genetic mutation.
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2.2. Introduction
Clonal populations often exhibit phenotypic heterogeneity, leading to specific
physiological effects that distinguish some cells from others (Elowitz, Levine, Siggia, &
Swain, 2002; Sampaio & Dunlop, 2020; Symmons & Raj, 2016). Variability can slightly
reduce fitness in a common environment but, in return, maximize it during environmental
perturbations (Engl, 2019; Symmons & Raj, 2016). For example, bacterial persister cells,
a phenotypic variant, can endure prolonged lethal antibiotic treatment by entering a
metabolically altered state (Nathalie Q Balaban et al., 2004). This small subpopulation can
reestablish infection after treatment and necessitate repeated long-term antibiotic therapy.
They also have a high mutation rate that increases the likelihood of evolving antibiotic
resistance, a pressing public health concern. A recent study provides evidence that among
infectious diseases, antibiotic resistance may be the leading cause of death worldwide
(more than HIV or malaria) (Murray et al., 2022). Global death projections are now
estimated at 100M/year by 2050 (Control & Prevention, 2019; Huemer et al., 2020) unless
new technologies are developed to combat them, and we have a better understanding of
persister survival. Here, we specifically focus on how heterogeneity in a population drives
persister numbers.
Noise or fluctuation in gene expression levels drives phenotypic variation that could
be an inherent survival strategy of a clonal bacterial population (El Meouche, Siu, &
Dunlop, 2016; Symmons & Raj, 2016). Studies reported that stress-response genes are
generally more variable than housekeeping genes (Bar-Even et al., 2006; Newman et al.,
2006). But it is uncertain whether this variability is controlled or an effect of inevitable
stochastic fluctuations in gene expression (Libby, Reuveni, & Dworkin, 2019). We
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formalize this notion and hypothesize that specific cells are prepared for stress through a
transiently inherited cell state.
In this work, we take advantage of the Luria & Delbrück fluctuation test (FT),
which was recently used to identify genes related to cancer persistence against cancer drugs
(Shaffer et al., 2020). Cancer persisters are similar in phenotype to bacterial persistence
but biochemically unrelated. We used a similar approach to probe bacterial persistence.
The FT was first pioneered ~80 years ago when Luria & Delbrück demonstrated that
genetic mutations arise randomly in the absence of selection but not in response to the
selection (Luria & Delbruck, 1943). They were studying phage (bacterial virus) infections.
During that time, it was debated whether mutations leading to resistance were directly
induced by the virus (Lamarckian theory) or if they developed randomly in the population
before viral infection (Darwinian theory). They designed an elegant experiment where
single cells were isolated and grown into clones and then infected by a phage (Fig. 3a).
The number of resistant bacteria was counted across clones. Suppose mutations are virusinduced (i.e., no heritable genetic component to resistance), where each cell has a small
and independent probability of acquiring resistance. In this case, clone-to-clone
fluctuations in the number of resistant cells should follow Poisson statistics (a memoryless
process). In contrast, if mutations occur randomly before viral exposure (spontaneous
mutation), the quantity of surviving bacteria will vary considerably across clones
depending on when the mutation arose in the clone expansion. The data clearly showed a
non-Poissonian skewed distribution for the number of resistant bacteria, validating the
Darwinian theory of evolution (Luria & Delbruck, 1943) (Fig. 3a ). This work led to a
Nobel Prize, and the FT remains the most commonly used method to measure mutation
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rates in microbes (G. I. Lang, 2018). While Luria-Delbrück focused on irreversible genetic
alterations driving phage resistance, here we use the FT to elucidate transient cell states
that originate via reversible non-genetic mechanisms (Bokes & Singh, 2021; Chang et al.,
2021; Shaffer et al., 2017; Shaffer et al., 2020). Notably, this generalized FT can be applied
when single cells reversibly switch between drug-sensitive and drug-tolerant states even
before treatment. Clone-to-clone fluctuations can be exploited to quantify these switching
rates rigorously (Saint-Antoine, Grima, & Singh, 2022). This approach has been key in
deciphering drug-tolerant cancer cells that arise stochastically even before drug exposure.
Thus cancer cells have a bet-hedging mechanism to survive sudden hostile extracellular
environmental changes (Chang et al., 2021; Shaffer et al., 2017; Shaffer et al., 2020). Here,
we are exploring ‘primed cells’ (cells prepared for stress and arise by a rare, transiently
inherited cell state) present before the treatment and prolonging survival once treatment
begins (Fig. 3b-e).
In this study, we applied the FT to indicate some cells are prepared for stress and
have an inherent transient memory. We applied this approach in conjunction with
mathematical modeling to elucidate stochastic phenotype-switching in response to
antibiotic stress, an inherent survival strategy that gives flexibility to a clonal population.
Our work demonstrates how heritable transient cell state changes can lead to variation in
persister numbers. Exploring this phenomenon can shed light on how bacteria endure
stress, a key question in persister research (N. R. Cohen et al., 2013; Windels et al., 2019).
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Figure 3. The Luria-Delbruck fluctuation test (FT).

11
a. Each clone starts from a single cell and is then infected by a phage (virus). If resistance
mutations are virus-induced, the number of resistant cells would follow a Poisson
distribution across clones. In contrast, if mutant cells arise spontaneously prior to viral
exposure, there will be considerable clone-to-clone fluctuations in the number of surviving
cells, including mutations that happen early in the lineage expansion causing many cells to
be resistant. b. FT to determine if some cells are primed for stress. This design follows the
same experimental setup as a., but it uses antibiotic stress and measures variation in
persister cells (cells in an altered cellular activity state by having transient gene expression
change) across the clones. If persisters are antibiotic-induced, then the number of persister
cells would follow a Poisson distribution across clones. In contrast, if there are primed cells
with a unique transient gene expression profile (caused by non-genetic factors) that allows
them to prepare for stress before antibiotic exposure, there will be considerable clone-toclone fluctuations in the number of surviving cells. Transient gene expression changes can
be heritable and happen early in the lineage expansion, causing many cells to become
primed for stress with a transient memory. c. Persister variation check in a single
population, referred to as NC: Noise control. Cultures were grown to mid-log phase, ~1E+8
CFU/ml, separated into 48 wells, treated with an antibiotic, 100 ug/mL Amp or Apr, and
plated before and after antibiotic treatment to get % Survival. d. Persister variation check
in clonal populations started from a single cell, referred to as FT. Cultures were diluted to
0.5 cell/well and treated similarly to a. e. A model for competing hypotheses; Induced
persistence: persisters are induced due to stress, and no difference will be observed in
persister variation between clonal populations and noise control. Primed persistence: some
cells are primed prior to stress; thus, some clonal populations will have more primed cells
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than others, and the persister variation will be higher in the clonal populations than in the
Noise control (NC).
2.3. Results
2.3.1. Primed cells prepared for stress before antibiotic treatment.
Bacterial populations are heterogeneous, even in log growth phase in a wellcontrolled lab environment, and especially in natural systems (Kearns & Losick, 2005;
Long, Hou, Ignacio-Espinoza, & Fuhrman, 2021). The quantification of persister numbers
often have huge variations with large error bars (SD or SEM), sometimes with 100s of fold
differences (M. Lang et al., 2021; S. G. Mohiuddin, Hoang, Saba, Karki, & Orman, 2020;
Salcedo-Sora & Kell, 2020). We used defined media, MMB+ (H. S. Deter et al., 2020; H.
S. Deter, T. Hossain, & N. C. Butzin, 2021)), which contains only chemically known
components, to minimize variations between experiments. We optimized and standardized
our experimental design, and reduced the internal error rate to below 2-fold. Much of this
error comes from the compounding imprecisions from multiple pipetting (all pipets have
an error rate, and these experiments require serial dilutions). Despite reducing the error
rate, we noticed that there would occasionally be huge outliers (up to 100-fold higher or
lower than the average).
We determined the typical persister variation in an E. coli population (Noise
control: NC) is higher than our internal error. We grew a culture to mid-log phase and then
divided it into 48 wells. We then treated it with ampicillin (Amp) or apramycin (Apr) for
3 h, followed by a persister assay (Fig. 3c). This resulted in a variation of ~6-fold for either
antibiotic. These results do not explain the 100-fold changes we occasionally observed.
Unable to explain the variation at the population level, we wondered if a "memory" was
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passed down over several generations and skewed our data. We set out to test for variations
from a single cell using a FT (Chang et al., 2021; Shaffer et al., 2017; Shaffer et al., 2020).
Cultures were diluted to about 0.5 cell/well (Limiting Dilution assay (Ye, Wilhelm,
Gentschev, & Szalay, 2021; Zitzmann et al., 2018)) in a 96-well microplate; on average,
48 wells had growth, and 48 wells did not (Fig. 3d). Cells were then grown to an OD of
0.4-0.6 (log phase) and treated with Amp for 3 h. Most (but not all wells) reach the desired
OD range simultaneously. We use two 96-well plates and pick 48 clones within the OD
range to deal with this. After treatment, the cells were plated on Petri dishes, grown, and
colonies were counted to get CFU/mL. We first tested lethal Amp dosages for 3 h, and the
persister range was vast, ~60-100-fold. We tested this several times (Fig. 4a; 8 separate
experiments with ~48 clones/experiment), and there is consistently an extensive range of
persister variation among the clones. We wondered if this was specific to Amp, so we
tested another class of antibiotic, Apr. Amp targets the cell wall (Rafailidis, Ioannidou, &
Falagas, 2007), while Apr targets the 30S ribosomal subunit (O'Connor, Lam, Jones, &
Chaney, 1976). Again, the persister range was vast, ~40-70-fold range with Apr (Fig. 4a).
We hypothesize that the extensive range in persistence is due to either (1) mutation or (2)
some cells are prepared for stress ("primed cells”), and these primed cells exhibited specific
characteristics which allow them to prepare prior to the stress. To assess if a mutation
causes this extensive persister range, we tested for antibiotic resistance by streaking clones
on antibiotic plates, and no resistant colonies grew (Fig 5a). To further test for mutations,
we diluted the high persister clone (Hp clone) into 0.5 cell/well and repeated the fluctuation
test. If a high persister clone was mutated, the average persister percentage would increase,
and the range would decrease. However, they had the same average persister percentage
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and similar range (~60-100 fold) in both fluctuation experiments (Fig. 4b i). If the cells
developed resistance, their minimum inhibitory concentration (MIC, the minimal antibiotic
required to hinder growth) would change. But it remained the same (Fig. 4b ii). These
results undoubtedly rule out mutations as the cause and led us to test hypothesis 2, that
some cells are primed prior to stress.

Figure 4. Some cells are prepared and primed for stress.
a. Results support primed persistence hypothesis: Population-level variation for Amp and
Apr: ~6 fold (experimental setup described in Fig. 1d). FT from single cell level
(experimental setup described in Fig. 1e): treatment with Amp or Apr shows 60 to 100-
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fold and 40 to 70-fold variation, respectively. b. Mutations do not cause persister level
variation among the clones. i. FT with wild-type clonal populations and FT with clonal
populations started from a high persister clone have a similar average persister level and
persister range among 48 clones. ii. MIC test showing no change in MIC level in high
persister clones. ***P<0.001.
2.3.2. Cell density is not the primary factor for variation in persister number.
Some bacterial persistence levels are controlled (in part) via quorum sensing
(Maisonneuve & Gerdes, 2014), which is a density-dependent response. Thus, before
testing hypothesis 2, we wanted to know how much cell density could skew our results by
testing the overall persister range with different cell densities using FTs. For FTs in (Fig.
4a), cells were harvested at OD 0.4-0.6 since the persister levels are remarkably similar at
these ODs. We detected no correlation between cell density and % Survival in 15 FTs (7
Amp and 8 Apr) and a weak correlation in FT3 with Amp treatment (Fig. 5b i). Thus, to
further determine how much cell density affects the persister levels, we tested persister
levels from OD 0.3 to 0.7 in ~0.1 OD intervals (cells are in log phase and cell density
ranges from ~2E07 to 2E08 CFU/mL) in a general population at 3 h Amp or Apr. No
appreciable correlation was observed with either antibiotic (Fig 5b ii).
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Figure 5. Mutation is not the reason for persister level variability among clones
a. Streaking plate shows mutation is not the reason for persister level variability among
clones. b. Cell density is not the reason for persister level variation among clones. i. Each
FT tests treated with Amp or Apr show no correlation between CFU/mL vs. % Survival.
ii. General populations treated with Amp or Apr show no correlation between CFU/mL vs.
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% Survival. c. FT started with 2-cells/well and showed ~78-fold variation among clones.
2.3.3. Cells are primed for persistence, not short-term tolerance.
Short-term tolerance can mask persistence, and experimental evidence has shown
that the phenotypes are distinct from each other (S. Ronneau, Hill, & Helaine, 2021). Shortterm tolerant cells are dividing and likely have different survival mechanisms than
persisters. In the initial stage of antibiotic treatment, there are far more short-term tolerant
cells than persister cells (Fig. 6a). We did a similar FT with clones grown from a single
cell and treated them with a lethal Amp concentration (100 ug/mL). % Survival was
determined for 1 h and 3 h of treatment using persister assays (H. S. Deter et al., 2020; H.
S. Deter et al., 2021; Hossain, Deter, Peters, & Butzin, 2021), and short-term tolerance at
1 h does not indicate the level of persistence at 3 h with lethal Amp; no correlation at 1 h
vs 3 h population (r2 = 0.02) (Fig. 6b). If the primed cells are advantageous for long-term
survival, we expect the high persister populations observed at 3 h treatment to stay high
with more prolonged antibiotic exposure. As expected, % Survival at 3 h highly correlates
with % Survival at 4 h (r2 = 0.85) and 5 h (r2 = 0.78) Amp treated population (Fig. 6c).
Therefore, our results demonstrate that cells are primed for persistence and not for shortterm tolerance.
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Figure 6. Cells are primed for persistence, not for short-term tolerance
a. A simplified model of population decay indicates a biphasic death curve where
susceptible cells or short-term tolerant cells die quicker than persisters. b. Compare each
clone's short-term tolerance levels (1 h Amp) to their persister level (3 h Amp). c. Compare
each clone's persister level at 3 h Amp to 4 h Amp or 5 h Amp (long-term persister level).
About 48 clones were grown from a single cell and treated with Amp (100 ug/mL), and the
% survival was determined at different time points. r: Pearson’s correlation coefficient; ns:
not significant.
2.3.4. Primed cells have transient memory.
Next, we determined whether high persister clones arise randomly due to noise in
gene expression levels or in rare events where the gene expression level (memory) is passed
down for several generations. We hypothesize that there is a transient memory at the
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transcriptomic level. The null hypothesis is that there is no memory and the variation range
in persistence is random and solely due to noise. To test this, we divided and diluted the
culture between 1:1 to 1:100 into separate microplates and allowed them to grow (Fig. 7a).
If the null hypothesis is correct, there should be no correlation between divided cultures.
However, persister levels were strongly correlated until the 1:20 dilution, and the memory
is completely lost after a 1:100 dilution, supporting our transient memory hypothesis (Fig.
7b). We further confirmed the transient memory hypothesis with Apr (Fig. 7c). These
results also add additional support that primed cells are not mutants, because 1:100 dilution
led to no long-term (genetic) survival phenotype (in several different clones), as a
resistance mutation would allow.
We hypothesize that the same primed cells will allow higher persister levels when
using antibiotics from classes that target distinct cellular processes, e.g. Amp and Apr. If
both Amp and Apr primed cells use an akin mechanism, we expect a reasonable correlation
between their persister numbers/well. If they do not correlate, diverse types of primed cells
likely exist. To understand this, we did experiments similar to (Fig. 7a), but we tested
Replica 1 with Amp and Replica 2 with Apr. In this case, both replicas had a transient
memory, and the memory was lost by 1:20 dilutions (Fig. 7d).
2.3.5. Primed cells are not spontaneous persisters.
Previous researchers proposed spontaneous persisters formation; persisters that are
generated stochastically at a constant rate during exponential phase growth and switch to a
dormant or a protected state (distinct slower growth rate than other cells, and this slowed
growth rate is maintained for several generations and turn into persisters in the presence of
stress) (Nathalie Q Balaban et al., 2019; Nathalie Q Balaban et al., 2004; Nadia R Cohen,
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Michael A Lobritz, & James J Collins, 2013). In addition, they proposed that during
exponential growth, these phenotypic variants (e.g. persister formation) could also be
induced by stress (Nathalie Q Balaban et al., 2004). However, several research groups
criticized the concept of spontaneous persister formation (Keren, Kaldalu, Spoering, Wang,
& Lewis, 2004; J. S. Kim & T. K. Wood, 2016), questioning if it exists or is a proper
terminology. In the original paper, where persistence was proposed in 1944, persisters were
defined as non-dividing cells (Bigger, 1944). However, spontaneous persisters were
defined as dividing cells (N. Q. Balaban, J. Merrin, R. Chait, L. Kowalik, & S. Leibler,
2004). Here we use the original definition of persisters; they do not divide. In addition, if
persister formation is only induced by stress, all cells in the population should turn into
persisters instead of a small percentage of the population. Also, induced persister formation
(or sense-and-respond strategies) could be costly for the cells since it necessities
constitutive expression of essential molecular machinery (Wakamoto et al., 2013).
On the contrary, primed cells (already prepared for stress in a population through
heterogeneity) could provide a simple mechanism for adaptation to stresses they might or
might not encounter. A key phenotype of spontaneous persisters is that they grow slowly.
However, we did not observe any significant growth rate changes among the clones, and
recent results demonstrate that persisters are not slow-growing before antibiotic treatment
(Goormaghtigh & Van Melderen, 2019). To further explore whether primed cells are
reliant on slow growth, we constructed a simple mathematical model (explained in the
Methods), where we plotted the fraction of persister cells

𝑦(𝑡)
𝑥(𝑡)

as a function of time for

persister proliferation being 100%, 90%, 80%, 50%, and 0% of the proliferation rate of the
drug-sensitive cells. We observed when persister cells do not proliferate (𝑘𝑝 = 0), their
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fraction rapidly dilutes back to the steady-state level in a few generations (Fig. 7e). These
results show that a high correlation in persister maintenance, as seen in Fig. 7b for several
generations, requires persister proliferation. For example, one requires 𝑘𝑝 = 0.9𝑘𝑑 for it
to take roughly 4 generations for the fraction of persisters to fall to 50% of its initial levels,
similar to the drop in the correlation between replicates to 0.5 in Fig. 7b. Our evidence
clearly shows that primed cells are not persisters (non-dividing cells) before antibiotic
treatment since they grow and maintain a transient memory.

Figure 7. Primed cells have transient memory.
a. Fluctuation test (FT) setup to check primed cell’s memory: cultures were diluted to 0.5
cells/well, grown to mid-log phase (~1E+8 CFU/mL), each clone is divided and diluted
into 2 replicates, grown to mid-log, and then tested for persistence. b & c. Primed cells
have transient memory for several generations before 3 h Amp and 3 h Apr treatment. The
persister levels correlate even with 1:20 dilutions between Replicate 1 and 2, suggesting a
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strong memory within the primed subpopulation. The memory is eventually lost with a
1:100 dilution. d. Primed cells show a weak memory when split and tested with Amp vs.
Apr. *Antibiotic: Amp vs. Amp (replicate 1 &2 both treated with Amp) or Apr vs. Apr
(replicate 1 & 2 both treated with Apr) or Amp vs. Apr (replicates 1 & 2 treated with Amp
and Apr, respectively). Axes are % Survival. r: Pearson’s correlation coefficient; ns: not
significant. e. Plot representing the fraction of persisters

𝑦(𝑡)
𝑥(𝑡)

as predicted by the

differential equation model (see Methods),
assuming that initially 10% of cells where persisters and the steady state persister level was
𝑓𝑠 = 1%. The five lines are plotted assuming the persister proliferation rate, 𝑘𝑝 =
𝑘𝑑 , 0.9𝑘𝑑 , 0.8𝑘𝑑 , 0.5𝑘𝑑 , 0 where 𝑘𝑑 = 1 and 𝑘2 = 𝑘𝑝 /10. The black dashed lines show
the numbers of generations it takes for (𝑡) =

𝑓(0)+𝑓𝑠
2

, when 𝑘𝑝 = 0.9𝑘𝑑 .

2.4. Discussion & Conclusion
Phenotypic heterogeneity is a fact of life and exists in both unicellular and
multicellular organism (Elowitz et al., 2002; Engl, 2019; Symmons & Raj, 2016). This
latent variation in phenotypic plasticity reveals in unfavorable environmental condition
(Engl, 2019). Noise in gene expression can drive this heterogeneity, and heterogeneity is
hypothesized to be a key player that regulates bet-hedging strategies to endure harsh
environmental fluctuation, such as bacterial persistence (Lyu, Yang, Villanueva, Singh, &
Ling, 2021; Symmons & Raj, 2016). Persisters have reduced efficacy to antibiotic
treatment and are a key contributor to the rise in antibiotic resistance. Unraveling the
underlying molecular mechanisms of heterogeneity is therefore crucial to comprehend
bacterial persistence.
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In this study, we used a powerful fluctuation test framework to infer transient cell
states that arise via reversible and non-genetic mechanisms, recently employed in probing
cancer persistence (Chang et al., 2021; Shaffer et al., 2017; Shaffer et al., 2020), to find
hidden features of bacterial persistence. Using the FTs, we tested the variation between
clonal populations that originated from an identical clone and showed that a subset of the
population, primed cells, have a "memory" that leads to high numbers of persisters. Our
results demonstrate that under the same conditions, phenotypic heterogeneity often occurs
in a range of ~60-100 and ~40-70 fold for Amp and Apr, respectively, despite (likely) being
driven by a stochastic noise in gene expression. The relative consistency in primed cell
numbers suggests that changes in specific genes result in primed cells, though we did not
experimentally explore the mechanisms of primed cells in this work. Having high numbers
of primed cells is a selective advantage that offers phenotypic plasticity to a bacterial
population experiencing frequent harsh environmental stress. This heritable transient state
might be favored in the course of evolution as a survival tactic compared to DNA mutation
because it requires no long-term commitment. A recent paper demonstrated a transient
cellular memory in E. coli, and that inheritance of non-genetic elements can help maintain
cellular memory (Vashistha, Kohram, & Salman, 2021). Thus, reducing variation among
new cells for a few generations (Vashistha et al., 2021). They found that some inherited
elements, cell size, and the time required for cell division were maintained for nearly ten
generations (Vashistha et al., 2021).
We did not explore experimentally the regulatory mechanisms behind primed cells
in this study, but we offered a mathematical model that supports and gives clues to the
regulation of the transient memory. However, a few possible mechanisms that bacteria
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employ are already known. DNA methylation is a common method of epigenetic regulation
in organisms, and many forms of methylation have been identified in bacteria (Adhikari &
Curtis, 2016; Beaulaurier, Schadt, & Fang, 2019; Casadesus & Low, 2006). Some are
related to antibiotic resistance or persistence (Cohen et al., 2016; Masuda et al., 2019). For
example, the deletion of dam, which is responsible for adenine methylation, can lead to
lower persister numbers in pathogenic E. coli strains (Xu, Liu, Zhang, & Zhang, 2021).
Another recent study showed multisite phosphorylation may regulate the phenotypic
variability in a bacterial population. A gene encoding ppGpp Synthetase, sasA, is regulated
by multisite phosphorylation of WalR and exhibits elevated levels of extrinsic noise in gene
expression. Due to this noise, cells having elevated levels of sasA expression have
increased short-term antibiotic tolerance (Libby et al., 2019). Another possible mechanism
could be ploidy. The Brynildsen group showed that ploidy or chromosome abundance
produces phenotypic heterogeneity that affects persister numbers. Stationary-phase E. coli
cells with two chromosomes had ~40-fold more persisters than cells with one chromosome
against fluoroquinolone antibiotic (Murawski & Brynildsen, 2021).
In this study, we have not dealt with viable but nonculturable (VBNC) cells. Several
studies showed VBNCs and persisters share similar phenotypes, and the major difference
between them is after stress (e.g. antibiotics), persisters can grow on Petri plates while
VBNCs can only grow in liquid. Currently, there is a furious debate if VBNCs are actually
persisters, simply dying cells, or if VBNCs even exist (Kirschner, Vierheilig, Flemming,
Wingender, & Farnleitner, 2021; McDougald, Rice, Weichart, & Kjelleberg, 1998;
Nystrom, 2001, 2003; S. Song & T. K. Wood, 2021). A recent study called in to question
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many of the indicators that are currently used to classify bacterial cells as alive or dead
(Barros, Melo, & Pereira, 2022).
We tested if VBNCs could be resurrected using the 0.5 cell/well technique. The 0.5
cell/well is based on cell counts on Petri dishes (CFU/ml). Often, VBNCs are cited as being
at equal concentrations (using a hemocytometer and microscope) as CFUs (Ayrapetyan et
al., 2018; Mehmet A Orman & Mark P Brynildsen, 2013b), but we did not observe this.
We observed a ~20% count difference (cell/mL) between hemocytometer and agar plate
count, which is within the hemocytometer’s manufacture error rate. However, still if
VBNCs are present and grow only in liquid, we expect 1 cell/well in a 96-wells plate when
using CFU/mL from Petri dishes. Instead, we consistently get ~48 wells had growth. We
also consistently get growth in ~24, ~12, and ~6 wells when we use 0.25, 0.125, and 0.0625
cells/well, respectively, with an r2 of 0.97, when plotting the wells with growth vs.
cells/well based on CFU/ml. Supplementing media with pyruvate may resurrect VBNCs
quicker (Morishige, Fujimori, & Amano, 2013; Vilhena et al., 2019). We tested the
addition of pyruvate after antibiotic therapy with two carbon sources: glycerol and glucose.
VBNCs did not resurrect; only ~48 wells had growth.
Recognizing that the previous assays do not account for all the nuances of VBNCs,
we tested whether VBNCs would alter our overall results using 2 cells/well (based on
CFU/ml). Again, we see a high variation with Amp treatment, ~78-fold (Fig. 5c). This
shows that if there are VBNCs, they are not skewing our results and that we still observe
primed cells even with 2 cells in each well. It also demonstrates that the FT does not require
1 cell/well, which is an important finding because it is unrealistic to assume that every well
we test will always have 1 cell when diluted to 0.5 cells/well.
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Overall, our findings show that a subset of the population has a transient memory
allowing them to prepare for antibiotic stress (we refer to them as ‘primed cells’). However,
further exploration is needed to determine the regulatory mechanism(s) behind this cellular
memory and the contribution of non-genetic factors in phenotypic heterogeneity.
2.5. Materials and Methods
2.5.1. Microbial strains and media.
Escherichia coli DH5αZ1 having the p24KmNB82 plasmid was used in this study.
We used this strain because DH5αZ1 was a derivative of E. coli K12 strain, and it has been
used in our previous persistence studies (H. S. Deter et al., 2020; H. S. Deter et al., 2021).
The cultures were grown in the defined media MMB+ (H. S. Deter et al., 2020; H. S. Deter
et al., 2021) with thiamine (10 μg/mL), 0.5% glycerol, Km (25 μg/mL), and amino acids
(40 μg/mL) or on Miller’s lysogeny broth (LB) agar plates +Km (25 μg/mL). For pyruvate
assays, MMB+ media were supplemented with 2 mM sodium pyruvate. All cultures were
incubated at 37°C and shaken at 300 rpm.
2.5.2. Population-level variation check (Noise control: NC).
We used two different types of antibiotics, Ampicillin (Amp, target cell wall
(Rafailidis et al., 2007)) and Apramycin (Apr, target 30S ribosome(O'Connor et al., 1976)),
for all fluctuation tests. We started with a mid-log phase E. coli culture having ~1E+8
CFU/mL (~OD 0.5), subsequently divided the culture into 48 well (48 replicate) of 96Well Optical-Bottom Plate with Polymer Base (ThermoFisher) and treated them with Amp
(100 ug/mL) or Apr (100 ug/mL) for 3 h at 300 rpm, 37°C in a FLUOstar Omega microplate
reader. Persister percentage was calculated by comparing CFUs per milliliter (CFU/mL)
before antibiotic treatment to CFU/mL after antibiotic treatment. Plates were incubated at
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37ºC for 48 h, then scanned using a flatbed scanner. Custom scripts were used to identify
and count bacterial colonies (Datla et al., 2017a; Heather S Deter, Dies, Cameron, Butzin,
& Buceta, 2019).
2.5.3. Fluctuation test (FT) from a single cell level.
We started with a log phase E. coli culture with ~1E+8 CFU/mL (~OD 0.5) and
subsequently diluted the culture into 0.5 cells per well in a 96-Well Optical-Bottom Plate
and grown in a FLUOstar Omega microplate reader at 37°C, 300 rpm. Each dilution
experiment was done twice for each single-cell experiment to confirm the dilution, and
cultures were only picked when 50-60% of the well had growth (48-55 wells out of 96
wells). The single cell was proliferated to mid-log phase ~1E+8 CFU/mL (~OD 0.5) and
treated with Amp (100 ug/mL) or Apr (100 ug/mL) for 3 h, 300 rpm at 37°C. The persister
percentage was calculated in the same manner described in the above section. The splitting
and dilution test was done exactly as above, except when the single cell proliferated into
mid-log phase, the cultures were separated and diluted into 2 plates with pre-warmed
MMB+ media. Then, the cultures were grown to exponential phase, and persister assays
were performed.
2.5.4. Antibiotic resistance assay.
After each fluctuation test, clones were diluted 1:100 in 1 mL LB media and were
grown for 12 h. The cultures were then centrifuged for 3 min at 16,000 x g. After that, the
supernatant was removed, and the pellet was streaked with and without antibiotic
containing LB agar plate and incubated at 37°C.
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2.5.5. Minimal inhibitory concentration (MIC) test.
Clones, including high persister clones from fluctuation tests, were diluted 1:100 in
1 mL LB media and grown for 12 h. First, 0.2 mL of culture was spread on an LB agar
plate, then a MIC strip was placed on top of it and incubated at 37°C.
2.5.6. Mathematical model.
To understand prime cell proliferation rate, we considered a model of persister
formation where drug-sensitive cells switch to a persister state with a rate 𝑘1 , and persister
cells revert back to the drug-sensitive state with a rate 𝑘2 . We assumed the rate of cellular
proliferation in the drug-sensitive and persisters states to be 𝑘𝑑 and 𝑘𝑝 , respectively. In an
expanding cell colony, the number of persister cells can be captured by the following
system of ordinary differential equations,
𝑑𝑥
= 𝑘𝑑 𝑥(𝑡) − 𝑘𝑑 𝑦(𝑡) + 𝑘𝑝 𝑦(𝑡)
𝑑𝑡
𝑑𝑦
= 𝑘𝑝 𝑦(𝑡) + 𝑘1 𝑥(𝑡) − 𝑘1 𝑦(𝑡) − 𝑘2 𝑦(𝑡)
𝑑𝑡
where 𝑥(𝑡) and 𝑦(𝑡) are the total number of cells and the number of persister cells,
respectively, at time 𝑡. By setting,
𝑘1 =

𝑓𝑠 (𝑘2 + (𝑘𝑑 − 𝑘𝑝 )(1 − 𝑓𝑠 ))
1 − 𝑓𝑠
𝑦(𝑡)

ensures that the steady-state persister fraction lim 𝑥(𝑡) = 𝑓𝑠 . We considered a clone that
𝑡→∞

initially had a high fraction of persister cells. We used the model to explore the relaxation
of persister numbers back to steady-state levels, and how this time scale particularly
depends on the persister proliferation rate 𝑘𝑝 . We then plotted the fraction of persister cells
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𝑦(𝑡)
𝑥(𝑡)

as a function of time for persister proliferation being 100%, 90%, 80%, 50% and 0%

of the proliferation rate of the drug-sensitive cells.
2.5.7. Cell counting.
Initially, using the common protocol for a hemocytometer, microscopic counting,
and live/dead dye, we saw about equal “VBNCs” per non-VBNCs in log and stationary
phase, and with lethal antibiotics. This is consistent with the literature (Ayrapetyan et al.,
2018; Mehmet A Orman & Mark P Brynildsen, 2013b). However, we adjusted our
counting protocol to match the manufacturer's recommendation. As a result, we no longer
see 2X the VBNCs compared to the CFU/ml; instead, the microscope count and Petri plate
count only varied by ~20 - 25% in log phase.
We attempted to use several live-dead dyes to calculate viability after antibiotic
treatment, but we found these assays to be quite unreliable, as recently cited in the literature
(Davey & Hexley, 2011; Kirchhoff & Cypionka, 2017; Rosenberg, Azevedo, & Ivask,
2019; Sooyeon Song & Thomas K Wood, 2021b; Stiefel, Schmidt-Emrich, ManiuraWeber, & Ren, 2015). So, we took the other approaches we described.
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3. ESCHERICHIA COLI CELLS ADJUST THEIR TRANSCRIPTOME PROFILE TO
SURVIVE LETHAL ANTIBIOTIC STRESS
3.1. Summary
Bacterial persisters, a multidrug tolerant subpopulation that are able to resuscitate
after antibiotic treatment and are considered to be the main cause behind relapsing
infections. They also increase the chances of gaining antibiotic resistance. To probe the
mechanism of persister, we conducted a transcriptomic analyses at multiple time points
when cells are under antibiotic stress. We compared transcription levels at 3 h, 6 h, and 24
h of ampicillin (Amp) treated persisters normalized to untreated controls (0 h). We
observed throughout an Amp time course, some genes were consistently upregulated
compared to 0 h; however, several genes were differentially expressed between samples
across the prolonged exposure. These findings suggest that cells are altering gene
expression to endure the stress. To investigate why and validate our transcriptomic
analysis, we overexpressed and make knockouts of some genes which were consistently
upregulated in all different time-points. When we overexpressed the hypothetical genes,
most of them cause the growth defect and some of them put the cells into sleepy state for
several hours. The knockout mutants decreased the persister level dramatically by ~4-6
fold and ~10-15 fold at 3 h and 6h of Amp treatment, respectively. However, at 24 h, it
showed no significant difference in survival from wild type which again showed that the
persister transcriptome adjusts its expression profile over time. Our result clearly
demonstrate that, persisters transcribe and translate and there are multiple mechanism
likely exist for persister survival.
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3.2. Introduction
All bacteria lead their lives in extreme environment and must cope with stress by
maintaing a altered metabolic state (widely known as persistence) (Nathalie Q Balaban et
al., 2004; Engl, 2019). Persistence is a bet-hedging strategy that all free-living bacteria
utilize to endure stress (Nathalie Q Balaban et al., 2004). Persisters are a small fraction of
the total bacterial population, and they arise from the population's phenotypic diversity (not
genetic mutations), have reduced cellular activity, and do not divide in presence of stress
(Lewis, 2012). This small subpopulation are considered to be one of the major cause for
recurrent infections since they can reestablish infection after treatment and necessitate
repeated long-term antibiotic therapy. Recent studies provides evidence that persisters also
have a high mutation rate and act as a major driving force behind the evolution of antibiotic
resistance—a pressing public health distress. Antibiotic resistance is one the leading cause
of death worldwide (more than HIV or malaria) (Murray et al., 2022), and global death
projections are now estimated at 100M/year by 2050(Control & Prevention, 2019; Huemer
et al., 2020) unless significant steps are taken to curb this disturbing trend. Thus, it’s an
urgent need to better understand the mechanism of persister survival.
Despite being discovered more than eight decades ago, the molecular mechanisms
responsible for persistence are still unclear and debated. An excellent method to determine
the essential genes/networks for persistence is to study the transcriptome profile (the entire
mRNA produced by cells at a specific time) of persisters using RNA-Seq. But, due of their
low abundance and intrinsic transient nature, it is enormously challenging to study their
transcriptomic profile. Thus, many previous transcriptomic studies have relied on sublethal concentrations or short-term exposure to lethal antibiotic concentrations. The
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populations investigated contained short-term tolerant cells (dividing, slow-growing cells)
but not necessarily persisters. Short-term tolerance can mask persistence, and experimental
evidence has shown that they are distinct from each other (S. Ronneau et al., 2021). Our
recent work reveals that high persistence levels do not correlate with high short-term
tolerance levels. Thus, it is important to use lethal antibiotic concentrations to investigate
persister transcriptional regulatory mechanisms.
The genes related to antibiotic survival are heavily debated because of conflicting results
and different interpretations of data. Some argue protein synthesis is slowed in persisters
due to slower transcription and translation rates(T. K. Wood et al., 2013), while others
provide evidence for ample protein synthesis (Yin et al., 2019). Other metabolic processes
such as oxidative respiration (Orman & Brynildsen, 2015) and antibiotic efflux (Y. Pu et
al., 2016) are also debated (J. S. Kim & T. K. Wood, 2016; Orman & Brynildsen, 2015;
Prax & Bertram, 2014; Y. Pu et al., 2016; T. K. Wood et al., 2013). The role of ATP and
the TCA cycle is particularly controversial (J. S. Kim & T. K. Wood, 2016; M. A. Orman
& M. P. Brynildsen, 2013; Orman & Brynildsen, 2015; Prax & Bertram, 2014; Y. Wang
et al., 2018). Much of the debate comes from looking at mixed tolerant and persister
populations, and only individual genes (not networks or clusters of genes). We previously
examined the entire gene network of only persisters (not tolerant cells) under long-term
stress such as antibiotic treatment, and then test the importance of genes in the network
using mutational studies.
In this study, we isolate RNA from persisters treated with high doses of an antibiotic for
sufficient time to kill short-term tolerant cells. We used a time-course assays followed by
mutation studies to test our hypothesis that the persisters transcriptome is not static but
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changes over time. This study is a follow-up of previous study where we showed that E.
coli survive antibiotics using an array of networks to respond. These networks
communicate to adjust the cellular response, and no single gene or a single network
controls this response. Individual genes or a single network can alter the ability of a
population to survive antibiotics(H. S. Deter et al., 2021).
3.3. Results
The overview of the experimental plan is shown in Fig 8. We harvested RNA from
persister subpopulation treated with lethal dose of a bactericidal antibiotic (ampicillin, a βlactam antibiotic that inhibits transpeptidase enzyme involved in cell-wall synthesis) for
sufficient time to kill short-term tolerant cells and then subjected for sequencing to analyze
the transcriptome profile of the persisters.
We previously showed that E. coli Dh5αZ1 strain displayed biphasic cell death
curve, where the short-term cells died quickly in the first phase, and the remaining cells
(persisters) survive longer showing slow and steady cell death which starts at 3h. One key
aspect of our procedure is we used rapid filtration (Bordag et al., 2016; Mohammad, Green,
& Buskirk, 2019) for large samples, followed by flash freezing in liquid nitrogen. Rapid
filtration allows us to isolate and wash cells quickly. Large-scale pelleting can be slow,
may alter the transcriptome, RNA can be degraded during harvesting, and we have
empirically shown that removing dead cells requires several washes when pelleting (but
not with rapid filtration). Though evidence supports that most RNA from dead cells is
unstable after death (Klein & Juneja, 1997; McIngvale, Elhanafi, & Drake, 2002; McKillip,
Jaykus, & Drake, 1999), RNA is sensitive to degradation by intra- and extra-cellular
RNases. This is why RT-qPCR is often preferred for detecting food pathogens or bacteria
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on surfaces over DNA (D'Souza, Critzer, & Golden, 2009; de Wet, Denman, Sly, &
McSweeney, 2008; Klein & Juneja, 1997; Malorny, Bunge, & Helmuth, 2007; McIngvale
et al., 2002; Miller, Draughon, & D'Souza, 2010; Sheridan, Masters, Shallcross, &
MacKey, 1998; Szabo & Mackey, 1999; Techathuvanan & D'Souza, 2011; Techathuvanan,
Draughon, & D'Souza, 2010; L. Wang, Li, & Mustapha, 2009; L. Wang & Mustapha, 2010;
Yaron & Matthews, 2002; Zhou et al., 2014); DNA is much more stable than RNA, making
DNA from dead cells detectable for a long time. Regardless, to further confirm assess the
expression findings from our transcriptome data, we used mutational study (e.g. gene
knockouts, gene overexpression, etc.).
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Figure 8. Schematic diagram of experimental design.
Mid-log phase cells were treated with Amp (100 ug/mL) for 24 h and RNA was isolated
from before and after antibiotic treated population at different time-points. Commonly
upregulated genes were selected for mutation studies.
3.3.1. Time-series persister transcriptome analysis showed differentially expression of
several genes.
We compared the expression profiles of a non-treated population (0h) to persister
subpopulation at multiple time-points (3 h, 6 h and 24 h). A total of 378, 1473 and 310
genes were differentially expressed in 3 h, 6 h and 24 h. Among them 160, 620 and 143
genes were upregulated at 3 h, 6 h and 24 h, respectively and 218, 858 and 167 genes were
downregulated at 3 h, 6 h and 24 h, respectively (Fig. 9a-c). Although we expected the
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number of downregulated gene might be way too low than upregulated genes due to the
presumed global shutdown of metabolic activity of persisters, but we observed
downregulated gene number is slightly lower than upregulated genes in all time points.
Comparing the genes at different time-points, we observed 27 genes were commonly
upregulated in all different time-points (Fig. 9d). Out of those 27 genes, we have identified
some uncharacterized genes (7 genes, listed on Table 1) that have not previously been
associated with antibiotic survival. For our next analysis, we selected 6 genes out of those
7 hypothetical genes. Another interesting hypothetical gene (yjbE) we choose for our
mutation studies because it showed highest expression at 6 h (10.23 fold) and 24 h (7.25
fold).
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Table 1. Commonly upregulated genes in different time-points of persister cells
Genes
3h
6h
24 h
Functions
acrB
2.33
3.65 2.01
Multidrug efflux pump RND permease AcrB
bioF
2.34
2.25 3.45
Play role in biofilm formation
hflC
2.05
3.24 2.09
Regulator of FtsH protease
iscX
2.95
2.18 2.66
Accessory iron-sulfur cluster assembly protein IscX
ivy
2.17
5.42 2.42
Periplasmic chaperone, inhibitor of vertebrate C-type
lysozyme
lspA
2.48
4.38 2.39
Lipoprotein signal peptidase
murD
3.38
4.41 2.12
Cell wall formation (probable)
rplL
2.31
3.65 2.08
50S ribosomal subunit protein L7/L12 dimer
rplO
2.17
3.65 2.85
50S ribosomal subunit protein L15
rplQ
2.26
3.97 3.37
50S ribosomal subunit protein L17
rpmD
2.34
3.57 2.74
50S ribosomal subunit protein L30
rpoA
2.01
3.60 2.85
RNA polymerase subunit α
rpsE
2.28
3.50 2.63
30S ribosomal subunit protein S5
rpsQ
2.45
3.41 2.36
rRNA binding proteins/plays a role in translational
accuracy
rpsU
2.60
5.45 3.47
30S ribosomal subunit protein S21
secY
2.08
3.39 2.45
Required for efficient protein translocation across the
cytoplasmic membrane
ycfJ
2.10
6.38 3.88 Uncharacterized protein, play role in biofilm formation
ygfB
3.41
3.55 2.51
Uncharacterized lipoprotein
yajI
4.15
7.33 4.37
Uncharacterized lipoprotein
yciF
3.71
4.11 3.41
Uncharacterized protein. Up regulated when bacteria
experience stress conditions, and is highly conserved in
a range of bacterial species.
yciY
3.21
6.11 5.68
uncharacterized protein
yfgD
3.02
4.00 3.29
uncharacterized protein
ykiA
3.62
3.55 3.88
Putative uncharacterized protein
ypeB
3.45
4.09 2.98
Uncharacterized protein
rcsA
2.88
8.31 5.02 Component of the Rcs signaling system, which controls
transcription of numerous genes
wcaB
3.04
7.54 4.27
Involved in the pathway slime polysaccharide
biosynthesis, which is part of Slime biogenesis.
rsfS

2.18

4.49

2.69

Ribosomal silencing factor RsfS
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Figure 9. Comparative transcriptome profile analysis of population before and after
antibiotic treatment.
Volcano plots for (a) 0 h (non-persister population) vs 3 h (persister population), (b) 0 h vs
6 h and (c) 0 h vs 24 h. Venn diagram for transcriptome comparison of (d) upregulated
genes, (e) downregulated genes and (f) stable genes on 0 h vs 3 h, 0h vs 6h and 0h vs 24 h.
Differentially expressed genes are defined to be those with p adjusted values <0.1 and fold
change higher or lower than ±2.
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3.3.2. Overexpression of hypothetical genes decrease growth rate.
We cloned all the selected hypothetical genes under IPTG/Ara promoter. When we
overexpressed the genes, most of them had significant growth defect. Among them,
overexpression of two genes (yjbE and yajI), put the cells into a nondividing, sleepy state
for several hours, and then the cells awoke on their own through mutation. We are referring
here mutation because we took the awoken cell and again induced them. But we did not
observe any growth defect between induced or un-induced conditions. The sleepy state is
likely related to the reduced cellular activity characteristic of persistence (Fig. 10).

Figure 10. Growth curve of E. coli strains cloned with hypothetical genes during
induced (Ara (0%); IPTG (100 uM) and un-induced condition (Ara (0.2%); IPTG
(100 uM).
3.3.3. Knockout of hypothetical genes reduces persister survival under antibiotic
treatment.
Next, we constructed knockout mutant of the hypothetical gene using CRISPR/cas9
based gene editing tool to test the effect(s) of a given gene at different time points of
ampicillin treatment. We did not observe any growth defect in the mutants (Fig. 11)
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However, when we tested the persister level in the mutants, all mutants decreased persister
level dramatically by ~4-5-fold and ~10-14-fold at 3 h and 6 h with Amp treatment,
respectively. Interestingly, we did not show any significant difference in persister level in
comparison to wild type at 24 h (Fig. 12). This result led us to two hypotheses- there might
be more than one subpopulation of persisters; or persisters use other backup mechanism to
compensate the loss of those hypothetical genes.

Figure 11. Knockout mutants did not show any growth defect in comparison to
wild-type.
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Figure 12. Persister level comparison between wild- type (WT) and knockout
mutants.
Overnight cultures of E.coli were grown to log phase (OD~0.5), treated with ampicillin
(100 ug/mL) for 24 h, and sampled at 3 h, 8 h and 24 h.. Error bars represent SEM (n ≥ 3).
There is 100% survival at time zero because percent survival is determined by the surviving
CFU/ml compared to the CFU/ml at time zero. *p < 0.05; **p < 0.01; *** p < 0.001
3.4. Discussion and conclusion
Persisters are often described as metabolically dormant and controlled by one or a few sets
of genes (J. S. Kim & T. K. Wood, 2016; Lewis, 2007; Y. Pu et al., 2016). Although
persisters are dormant with respect to growth, but they render an active response against
antibiotics (H. S. Deter et al., 2021; J. S. Kim & T. K. Wood, 2016). Here, we argued that
persister have an altered cellular activity rather than being in a dormant state. Using
CRISPR/Cas9 gene editing tool we mutated 7 hypothetical genes and observed their effect
on persister survival, which validated the biological relevance of our transcriptomic
analysis. Our result also demonstrated that not a single gene or network is responsible for
persister formation, it’s a network response. In this research, we showed persisters in a
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different light and we showed that persister can adjust their transcriptome to survive lethal
antibiotic stress. This knowledge will shift the paradigm of current persister research and
could be the key to understand this complex phenomenon.
3.5. Materials and Method
3.5.1. Microbial strains and media.
Escherichia coli DH5αZ1 having p24KmNB82 plasmid was used in this study. We
used this strain because DH5αZ1 was a derivative of E.coli K12 strain and it has been used
in our previous persistence studies(Heather S Deter, Abualrahi, et al., 2019; Heather S
Deter et al., 2021). The cultures were grown in modified MMA media, which we refer here
as MMB+. MMB media consists of the following: K2HPO4 (10.5 mg/mL), KH2PO4 (4.5
mg/mL), (NH4)2SO4 (2.0 mg/mL), C6H5Na3O7 (0.5 mg/mL), and NaCl (1.0 mg/mL).
Additionally, MMB+ consists of MMB and the following: 2 mM MgSO4·7H2O, 100 μM
CaCl2, thiamine (10 μg/mL), 0.5% glycerol, and amino acids (40 μg/mL). Cultures were
grown in MMB+ Kanamycin (Km, 25 μg/mL) or on Miller’s lysogeny broth (LB) agar
plates +Km (25 μg/mL). All cultures were incubated at 37 °C and shaken at 300 rpm.
3.5.2. Persister assay.
Overnight cultures were diluted 1/100 into fresh media and grown until they reach
between OD600 ~0.1- 0.2. A reduced volume of culture (10 mL) was aliquoted into three
100 mL flask, and grown for ~2-3 h until the culture reached to mid-log phase having
~1E+8 CFU/mL (~OD 0.5). After that, the culture was treated with bactericidal
concentration of Amp (100 ug/mL) for 3 h at 250 rpm, 37°C. Persister percentage was
calculated by comparing CFUs per milliliter (CFU/mL) before antibiotic treatment to
CFU/mL after antibiotic treatment. Plates were incubated at 37ºC for 48 h, then scanned
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using a flatbed scanner. Custom scripts were used to identify and count bacterial colonies
(Datla et al., 2017a; Heather S Deter, Dies, et al., 2019). For the time-kill curve, antibiotic
treatment was extended to 24 h, and number of persisters was recorded at 3h, 6h and 24h.
3.5.3. RNA sample prep and sequencing.
We used our previously developed methodology to harvest RNA from persisters
(H. S. Deter et al., 2021). Cultures are first treated with lethal Amp (100 ug/mL)
concentrations, and their transcriptomes are isolated and compared to an untreated
population. In brief, samples were treated with Tween (0.2%) and chloramphenicol (5
µg/ml) then immediately filtered out of solution (using rapid filtration) and resuspended in
lysis buffer containing 25 mM Tris pH 8.0, 25 mM NH4Cl, 10 mM MgOAc, 0.8% Triton
X-100, 0.1 U/µL RNase-free DNase I, 1 U/μL Superase-In, ~ 60 U/µl ReadyLyse
Lysozyme, 1.55 mM Chloramphenicol, and 17 μΜ 5′-guanylyl imidodiphosphate
(GMPPNP). Rapid filtration allows for the harvesting of any whole-cell; this minimizes
RNA degradation because samples are immediately frozen in liquid nitrogen have
suspension in lysis buffer. The solution was then frozen in liquid nitrogen and stored at −
80 °C. Frozen pellets were thawed on ice and centrifuged for 20 min at 16,000×g at 4 °C
with 0.3% Sodium Deoxychorate to pellet particulate matter. The supernatant was then
removed, and then RNA was column purified (Qiagen miRNeasy cat. No. 217004) before
removing rRNA (Invitrogen RiboMinus cat no. K155004) and prepping the cDNA libraries
(NEBNext Ultra II cat no. E7103S). Libraries were multiplexed then pooled and sequenced
by Illumina HiSeq paired-end sequencing by GENEWIZ. The data is analyzed using a
combination of Geneious Prime NGS software (Kearse et al., 2012), custom Python scripts
modified from our previous transcriptome analyses (H. S. Deter, Jensen, Mather, & Butzin,
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2017), and the DESeq2 R package (Love, Huber, & Anders, 2014). We consider significant
changes in gene expression to be greater than two-fold with an adjusted p-value <0.1.
3.5.4. Overexpression of hypothetical genes.
Since our control strain contains the plasmid p24KmNB82 (CFP-LAA), we cloned
the seven selected hypothetical genes under same promoter (Plac/ara) and ribosome
binding sites as in ref (Datla et al., 2017b). Our control strain Dh5αZ1 produces two
proteins (genes are on the genome), AraC and LacI, which are used to control the
expression of genes through the Plac/ara-1 promoter. AraC is an activator in the presence
of arabinose, while LacI is a repressor of this promoter. Isopropyl β-D-1thiogalactopyranoside (IPTG) acts as a repressor of LacI, thus allowing for the activation
of the Plac/ara-1 promoter. We used both arabinose (0.2%) and IPTG (100 uM) to express
the hypothetical genes.
3.5.5. Knockout of hypothetical genes.
To knockout the hypothetical genes, we used the clustered regularly interspaced
short palindromic repeats (CRISPR)-associated nuclease 9 (Cas9)-based genome editing
tool pEcCas/pEcgRNA system explained in ref (Q. Li et al., 2021) with slight modification.
In brief, 40 uL of competent cells containing pEcCas plasmid was added with pEcgRNA
plasmid (~200ng - 800ng), and donor dsDNA (~200ng - 800ng). Then, the mixture was
electroporated in a precooled 2 mm Gene Pulser cuvette (Bio-Rad, Hurcules, USA) at
1.8kV, 25uF, 200 ohms. After electroporation, freshly prepared 1mL of SOC media
(containing 1.5% arabinose) was added, and the culture was shake for 1 h at 250 rpm, 37℃.
Then, the culture was plated on LB + Amp (100 ug/mL) + Km (50 ug/mL) plates and
incubated at 37 ℃ for 24h. Each knockout was confirmed by colony PCR and sequencing.
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After the knockout, edited clone was inoculated into 10 ml of LB with Km (50 ug/mL),
and 100 mM rhamnose and grew for 12 hours at 37 ℃ to cure pEcgRNA plasmid. Then,
the culture was again transferred to 10 ml of LB with no antibiotics and grew for overnight
at 37 ℃ to cure pEcCas plasmid. Then, the culture was plated on LB agar with 5% sucrose
plate and incubated for overnight at 37 ℃. Finally, ~48 colonies from sucrose plates were
streaked on LB, LB+Amp (100ug/mL), and LB+Kan (50 ug/mL) plates, and incubated at
37 ℃ overnight. Colonies that only grew on LB plates are selected as our knockout strain.
Finally, we transformed p24kmNB82 plasmid in each of our knockout strain to keep it
similar to our control strain.
3.5.6. Determination of growth curve.
Overnight cultures were diluted into OD 0.1 (measured in SpectronicTM 200E) and
30 μL of diluted cultures were inoculated into individual wells containing 270 μL of SP16
media in a 96-Well Optical-Bottom Plate with Polymer Base (Thermo Fisher) to measure
OD at 600 nm using FLUOstar Omega microplate reader.
3.5.7. Statistical analysis.
All data is presented in the manuscript as mean ± SEM of at least three independent
biological replicates. Statistical significance was assessed using an f-test to determine
variance (p < 0.05 was considered to have significant variance), followed by a two-tailed
t-test with unequal variances (if F statistic > F critical value) or equal variances (if F statistic
< F critical value).
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4. ANTIBIOTIC TOLERANCE, PERSISTENCE, AND RESISTANCE OF THE
EVOLVED MINIMAL CELL, MYCOPLASMA MYCOIDES JCVI-SYN3B.
4.1. Summary.
Antibiotic resistance is a growing problem, but bacteria can evade antibiotic
treatment via tolerance and persistence. Antibiotic persisters are a small subpopulation of
bacteria that tolerate antibiotics due to a physiologically dormant state. Hence, persistence
is considered a major contributor to the evolution of antibiotic-resistant and relapsing
infections. Here, we used the synthetically developed minimal cell Mycoplasma mycoides
JCVI-Syn3B to examine essential mechanisms of antibiotic survival. The minimal cell
contains only 473 genes, and most genes are essential. Its reduced complexity helps to
reveal hidden phenomenon and fundamental biological principles can be explored because
of less redundancy and feedback between systems compared to natural cells. We found that
Syn3B evolves antibiotic resistance to different types of antibiotics expeditiously. The
minimal cell also tolerates and persists against multiple antibiotics. It contains a few
already identified persister-related genes, although lacking many systems previously linked
to persistence (e.g. toxin-antitoxin systems, ribosome hibernation genes, etc.).
4.2. Introduction
The evolution of antibiotic resistance is a pressing public health concern in the 21st
century; antibiotic resistance results from one or more genetic mutations that counteract an
antibiotic (Van den Bergh et al., 2016). Resistance is regarded as the primary culprit of
antibiotic treatment failure, but bacteria also employ less publicized strategies to evade
antibiotic treatment, namely antibiotic tolerance and persistence (Fisher, Gollan, &
Helaine, 2017; Alexander Harms, Maisonneuve, & Gerdes, 2016; Lewis, 2010). Persisters
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are a subpopulation of tolerant cells, which can sustain longer against antibiotic treatment
in comparison to slow-growing dying cells by entering a metabolically repressed state
(non-multiplying cells) (Cabral, Wurster, & Belenky, 2018; Fisher et al., 2017). Most
antibiotics are only effective against growing cells, and by not growing, the persister
population can survive longer even without being genetically resistant. Here, we define
persisters based on a kill curve and the original paper where persistence was proposed
(Bigger, 1944) (our definition of persistence is explained in detail in the discussion). Two
types of persisters may exist, triggered persisters (formed by environmental stimuli) and
spontaneous persisters (generated stochastically) (Nathalie Q. Balaban et al., 2019;
Nathalie Q Balaban et al., 2004; Sulaiman & Lam, 2020; Uruén, Chopo-Escuin,
Tommassen, Mainar-Jaime, & Arenas, 2021), although spontaneous persister formation is
controversial and evidence is sparse (Keren, Shah, Spoering, Kaldalu, & Lewis, 2004; J.S. Kim & T. K. Wood, 2016; Mehmet A Orman & Mark P Brynildsen, 2013a). What makes
persisters medically relevant is that they can revive and give rise to a new progeny after
antibiotic treatment; the new progeny can be genetically identical to the original susceptible
kin, and this process plays a pivotal role in recurring infections (D. Wilmaerts et al., 2019).
Furthermore, evolutionary studies have determined that repeated exposure to antibiotics
over many generations rapidly increases tolerance leading to antibiotic resistance (Balaban
& Liu, 2019; Nadia R Cohen et al., 2013; Fridman, Goldberg, Ronin, Shoresh, & Balaban,
2014; J. Liu, Gefen, Ronin, Bar-Meir, & Balaban, 2020; Schumacher et al., 2015; Sulaiman
& Lam, 2020; Van den Bergh et al., 2016).
The precise molecular mechanisms underlying persistence are still debated
(multiple mechanisms are likely to exist), albeit several genes have been implicated
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(Dorien Wilmaerts, Herpels, Michiels, & Verstraeten, 2019; Wu et al., 2015). Toxinantitoxin (TA) systems have been implicated in persistence and were previously thought
to be the key players for persistence (Lewis, 2010, 2012; X. Wang & Wood, 2011).
Particularly important is the HipAB TA system, because a toxin mutant, hipA7, increases
persistence by impeding cellular growth in the absence of its cognate antitoxin hipB
(Moyed & Bertrand, 1983). Subsequent studies also report that overexpression of other TA
systems’ toxins increased persistence (Correia et al., 2006; Kim & Wood, 2010; Korch &
Hill, 2006). In contrast, new research found that the deletion of 10 TA systems (~22% of
TA system in the genome) in E. coli does not have an apparent effect on persistence both
at the population and single-cell levels (Goormaghtigh et al., 2018), though E. coli can
have more than 45 TA systems (Horesh et al., 2018; Karp et al., 2014; Xie et al., 2018).
Though this work supports that TA systems are not controlling persistence, the remaining
35 TA systems (~78%) could be controlling this phenomenon. Mauricio et al. studied
persistence on Δ12TA Salmonella enterica and demonstrated that TA systems are
dispensable (Pontes & Groisman, 2019), although this strain has 18 predicted TA systems
based on the TAfinder tool (Xie et al., 2018). Another knockout study on Staphylococcus
aureus deleted three copies of type II TA system from the Newman strain (Conlon et al.,
2016). But further studies identified several type-I (sprG1/sprF1, sprG2/sprF2,
sprG4/sprF4) (Riffaud, Pinel-Marie, Pascreau, & Felden, 2019) and type-II (SavRS) (Wen
et al., 2018) TA system in HG003 and NCTC-8325 strains, respectively. These are the
parental strains of Newman, and these TA genes are also found in the Newman strain (Sassi
et al., 2015). Moreover, a recent study showed that antitoxin sprF1 mediates translation
inhibition to promote persister formation in S. aureus (Pinel-Marie et al., 2021). These
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findings raise many questions about TA systems’ implication in bacterial persistence
(Goormaghtigh et al., 2018; J.-S. Kim & T. K. Wood, 2016; Pontes & Groisman, 2019;
Tsilibaris, Maenhaut-Michel, Mine, & Van Melderen, 2007). There are major limitations
of studying TA systems in native bacteria due to their high abundance in most bacterial
genomes; they often have redundant and overlapping functions and can have
interdependencies within network clusters (A. Harms, Brodersen, Mitarai, & Gerdes, 2018;
Séverin Ronneau & Helaine, 2019; Xiaoxue Wang et al., 2013). Additionally, TA systems
respond to a variety of stresses (e.g. bacteriophage infection, oxidative stress, etc.), which
creates a hurdle to probe their connection with any phenomenon related to stress response,
namely antibiotic tolerance and persistence (A. Harms et al., 2018; Kang, Kim, Jin, & Lee,
2018; Séverin Ronneau & Helaine, 2019). TA systems are also involved in other
mechanisms in the cell that respond to stress, such as the stringent and SOS responses
(Séverin Ronneau & Helaine, 2019), virulence (De la Cruz et al., 2013), and the regulation
of pathogen intracellular lifestyle in varied host cell types (Lobato-Marquez, MorenoCordoba, Figueroa, Diaz-Orejas, & Garcia-del Portillo, 2015). Furthermore, new types of
TA systems may be yet unidentified. These challenges could be resolved using a strain that
lacks canonical TA systems. But TA systems are naturally abundant, and large-scale
knockouts are both error-prone and labor-intensive. We took advantage of the recently
developed minimal cell that does not encode any sequences displaying homology to known
TA systems and showed that it can still form persisters.
Several other mechanisms have also been considered in persister research including
SOS response, oxidative stress response, etc. (Trastoy et al., 2018; Dorien Wilmaerts et al.,
2019; D. Wilmaerts et al., 2019). Two extensively studied phenomenon related to
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persistence are cellular ATP levels and (p)ppGpp levels. The accumulation of (p)ppGpp
(stress sensing alarmone) mediates the stringent response, which controls a stress-related
persistence mechanism (Alexander Harms et al., 2016). (p)ppGpp regulates many networks
(such as ribosome dimerization) that can cause cells to go into dormancy (Gaca, ColomerWinter, & Lemos, 2015; Sooyeon Song & Wood, 2020; Thomas K Wood & Song, 2020).
Another well-studied model, ATP depletion increases persistence, has drawn much
attention in persister research (Conlon et al., 2016). This finding is consistent with recently
published result by Pu and colleagues (Pu et al., 2019), which demonstrated that lower ATP
levels lead to protein aggregation and increased tolerance. This result is also coherent with
our recently published data, which established that interfering with protein degradation by
forming a proteolytic queue at ClpXP will increase tolerance levels dramatically (Heather
S Deter, Abualrahi, et al., 2019). Transcriptomic analysis of queuing-tolerant population
showed upregulation of genes related to metabolism and energy (Heather S. Deter,
Hossain, & Butzin, 2020). However, other studies reported that ppGpp and ATP reduction
are not essential for persistence (Bhaskar, De Piano, Gelman, McKinney, & Dhar, 2018;
Chowdhury, Kwan, & Wood, 2016; Pontes & Groisman, 2019). These contradictory
studies are common in persister research, and we hypothesize these inconsistencies are due
to the interconnection of gene networks surrounding persistence.
One goal of our study is to clarify mechanisms using a minimal, simpler system.
Research over the last several years has resulted in a lot of discussion concerning genes
essential for persistence (Pontes & Groisman, 2019; Séverin Ronneau & Helaine, 2019;
Dorien Wilmaerts et al., 2019; D. Wilmaerts et al., 2019). Since persistence and tolerance
are present in phylogenetically diversified bacterial species (Meylan, Andrews, & Collins,
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2018; D. Wilmaerts et al., 2019), it is feasible that an underlying genetic mechanism is
conserved in evolutionarily related microorganisms, and the most likely candidates are
essential genes or the disruption of crucial networks. In our recent work, we demonstrate
that antibiotic tolerance in Escherichia coli may result from a whole-cell response and can
occur through multiple pathways or networks, which may work simultaneously and
cooperatively to survive against antibiotics (Heather S. Deter et al., 2020).
Our strategy to study the underlying mechanisms of persistence was to use a
bacterial species that contains mainly essential genes and networks with reduced
complexity and fewer networks. The minimal system can reveal hidden phenomena (Glass,
Merryman, Wise, Hutchison, & Smith, 2017) of antibiotic survival. For example, genes
and networks that have previously been identified can be eliminated as causal if the genome
lacks them. In contrast, genes present in Syn3B that were previously identified in other
organisms can become the focus of the work. The reduced complexity has its limits as there
are likely several methods microbes use to survive antibiotics, and not all methods will be
in a minimal system. With these limitations well-understood, we explored antibiotic
tolerance, persistence, and resistance in the minimal cell Mycoplasma mycoides JCVISyn3B (called Syn3B throughout), a synthetic genetic background that contains the least
number of genes and smallest genome of any known free-living organism (Syn3B contains
473 genes and its genome is ~531 Kbp long, while E. coli contains >4,000 genes and its
genome is ~4,600 Kbp long). The Syn3B genome was minimized from Syn1.0 (contains a
chemically synthesized genome of M. mycoides subspecies capri with some watermarks
and vector sequences) by removing non-essential genes (Gibson et al., 2010; Hutchison et
al., 2016). Syn3B consists predominantly of essential and a few non-essential (added for
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ease of genome manipulation) and quasi-essential genes (required for robust growth)
(Hutchison et al., 2016). This microbe was designed to have a minimal number of genes
and networks with the expectation that many of the first principles of cellular life could be
explored in the simplest biological systems (Glass et al., 2017). We show that Syn3B
populations contain both persister and tolerant cells, and its genome contains a few
previously identified persister-related genes. This work establishes that many systems
previously shown to be related to bacterial persistence, such as TA systems and ribosome
dimerization, are not essential for persistence in the minimal cell, and it demonstrates the
effectiveness of using the minimal cell to study antibiotic survival.
4.3. Result
4.3.1. Whole-genome analysis of the evolved minimal cell.
Although the minimal genome (Syn3B) was designed for ease of genetic
manipulation, Syn3B grows slowly and to a low cell density. We adjusted the original SP4
media (Tully, Rose, Whitcomb, & Wenzel, 1979) to address these limitations. The new
media, SP16, allows for faster cell growth and higher yields in liquid cultures. We noticed
that Syn3B growth was slightly better after every subculture. Thus, we did a cyclic
subculture of Syn3B in our optimized media by passing cells during logarithmic growth.
After 26 passages, we observed better growth and isolated a single colony named Syn3B
P026 (Pass 26). This strain has a shorter lag phase and an increased growth rate; the average
doubling time of P026 is approximately 2.5 hours compared to the ancestral Syn3B
doubling time of ~6 hours under the same conditions (Fig. 13.A-B). We performed a
whole-genome analysis of Syn3B P026 to examine the genetic basis of these changes. Most
of the mutations (9 of 11) in P026 are intergenic except one synonymous (fakA) and one
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non-synonymous (dnaA) (Table 2). fakA is a fatty acid kinase, and there is less evidence
to suggest a direct connection to substantial alterations in bacterial growth. dnaA is a
positive regulator of DNA replication initiation. Considering that bacterial growth rate is
dependent on the frequency of DNA replication and that dnaA mutants have been known
to result in over-replication (Skarstad & Boye, 1994), we hypothesize that the mutation of
dnaA in P026 could be responsible for the higher growth rate.

Figure 13. Growth of the minimal cell.
(A) Growth curve and (B) doubling time of evolved strain Syn3B P026 and parent strain
Syn3B. Error bar represents SEM. n = 12 independent biological replicates. *p<0.05,
**p<0.01, ***p<0.001, ****p < 0.0001.
Table 2. Mutation of Mycoplasma mycoides JCVI-Syn3B, and Whole Genome Sequence
(WGS) analysis identified the mutations (bold and underlined).
All antibiotic-resistant mutant strains were named based on the number of passes (P) in a
specific antibiotic (K: Ksg, S: Strep, C: Cip, SC: Strep-Cip). All antibiotic-resistant
mutants were selected from two separate evolutionary lineages, and named L1 for lineage
1 or L2 for linage 2.
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Syn3B
Strains
Parent*
P026

KsgR
PK07-L1

PK07-L2

Intergenic
mutationa

Mutation
positionsb

Genotype
change

Amino acid
substitution

Gene

Gene Annotation

9

547

GCA → ACA

Ala → Thr

dnaA+

274928

TAC → TAT

Tyr → Tyr

fakAc+

Chromosomal replication
initiator protein DnaA
Dihydroxyacetone kinase

479174

CCT → ACT

Pro → Thr

rpoC+

3322

GGA → GAA

Gly → Glu

ksgA+

479174

CCT → ACT

Pro → Thr

rpoC+

3322

GGA → GAA

Gly → Glu

ksgA+

101452
33652
101452
147803
33652

AAA → AGA
GGA → AGA
AAA → AGA
AGC → ATC
GGA → AGA

Lys → Arg
Gly → Arg
Lys → Arg
Ser → Ile;
Gly → Arg

rpsL+
CDS_6+
rpsL+
rpsD+
CDS 6+

30S ribosomal protein S12
Unknown
30S ribosomal protein S12
30S ribosomal protein S4
Unknown
DNA gyrase subunit A
DNA topoisomerase 4
subunit A
DNA gyrase subunit A
DNA topoisomerase 4
subunit A
DNA topoisomerase 4
subunit B
Unknown

8

8

StrepR
PS04-L1

4

PS04-L2

3

CipR
PC06-L1

4

7735
305613

GAA → AAA
GAT → AAT

Glu→ Lys
Asp→ Asn

gyrA+
parC+

PC06-L2

4

7735
305613

GAA → AAA
GAT → AAT

Glu→ Lys
Asp→ Asn

gyrA+
parC+

304707

GAT → GCT

Asp→ Ala

parE+

33652

GGA → AGA

Gly → Arg

CDS_6+

DNA-directed RNA
polymerase subunit beta
16S rRNA (adenine(1518)N(6)/adenine(1519)-N(6))dimethyltransferase
DNA-directed RNA
polymerase subunit beta
16S rRNA (adenine(1518)N(6)/adenine(1519)-N(6))dimethyltransferase

R

Strep CipR
PSC09-L1

4

7725
101452
33652
305602

AGT → AGG
AAA → AGA
GGA → AGA
AGT → ATT

Ser→ Arg
Lys → Arg
Gly → Arg
Ser→ Ile

gyrA+
rpsL+
CDS_6+
parC+

PSC09-L2

4

7725
101452
33652
305602

AGT → AGG
AAA → AGA
GGA → AGA
AGT → ATT

Ser→ Arg
Lys → Arg
Gly → Arg
Ser→ Ile

gyrA+
rpsL+
CDS_6+
parC+

DNA gyrase subunit A
30S ribosomal protein S12
Unknown
DNA topoisomerase 4
subunit A
DNA gyrase subunit A
30S ribosomal protein S12
Unknown
DNA topoisomerase 4
subunit A

*Parent: High growth rate mutant parent to all of the strains in the table.
a.
Mutation in the non-coding DNA sequences located between genes.
b.
Genomic position numberings correspond to Mycoplasma mycoides JCVI-Syn3B and
P026 (CP053944).
c.Synonymous mutation: mutation does not change in the encoded amino acid sequence.
+
Mutated genes are likely to be functional, although the mutated genes' functionality has
not been tested in this study.
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4.3.2. Syn3B and evolved minimal cell P026 display antibiotic tolerance and persistence.
We assessed tolerance and persistence (Fig. 14) of Syn3B (parent strain) and Syn3B
P026 cultures using two bactericidal antibiotics, ciprofloxacin (a fluoroquinolone) and
streptomycin (an aminoglycoside). Ciprofloxacin inhibits DNA replication by targeting
DNA gyrase and topoisomerase IV activity (Sanders, 1988). Streptomycin blocks protein
synthesis by irreversibly binding to the 16s rRNA of the 30S ribosomal subunit (Luzzatto,
Apirion, & Schlessinger, 1968). Syn3B and P026 were grown to stationary phase and
diluted into fresh media containing the antibiotics to observe population decay (see
Methods). Both parent strain and P026 cultures showed a typical biphasic death curve from
stationary phase; the death rate became slower at ~20-24 h treatment with both antibiotics
compared to the earlier stage of population decay, which indicates Syn3B displays
persistence (Fig. 14B-C). It appears that the survival was slightly higher in the Syn3B
ancestor strain than P026 for both antibiotic treatments. We posit that it could be due to the
slower growth rate of ancestor strain, which is consistent with the literature, as several
research groups already establish that growth rate has a strong correlation with antibiotic
susceptibility (Abshire & Neidhardt, 1993; A. J. Lee et al., 2018; Pontes & Groisman,
2019; Tuomanen, Cozens, Tosch, Zak, & Tomasz, 1986). As we observed tolerance and
persistence in both the ancestor strain and Syn3B P026, we decided to do further analysis
with Syn3B P026, because it was much easier to work.
Persister cells have been identified in native bacterial species in both stationary and
exponential phase cultures, and we tested if this was also true for the minimal cell. P026
was grown to exponential phase and treated with antibiotics to determine whether the
minimal genome showed a similar biphasic death curve in exponential phase. As expected,
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we observed a similar biphasic killing curve in exponential phase with slightly lower
survival in exponential phase compared to stationary phase for both antibiotics (Fig. 14D)
Moreover, we performed resistance assays through the course of this work to rule out the
possibility of resistance instead of tolerance or persistence (see Methods), and no resistant
colonies were identified. We then tested if the surviving population had increased persister
levels after antibiotic treatment. After 48 h of antibiotic treatment, the culture was passed
into fresh media and then grown to stationary phase. The culture was then exposed to the
same antibiotic under the same condition, and as expected, no significant difference
between the two death curves was observed (Fig. 15).

Figure 14. Population decay during antibiotic treatment shows Syn3B persistence.
A. A simplified model of population decay having two phases: short-term tolerance phase
and long-term tolerance phase. Both phases contain heterogeneous populations. The shortterm tolerant phase contains susceptible cells, slow-growing cells, transient tolerant cells,
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persister and viable but nonculturable cells (VBNCs). Transient tolerant cells survive
longer than fast-growing susceptible cells, while transient tolerant cells die quicker than
the persisters and VBNCs (VBNCs and persisters were not distinguished in this study).
The long-term tolerant phase contains both persisters and VBNCs. B. Population decay of
Syn3B (parent strain). Overnight cultures of Syn3B (parent strain) were grown to stationary
phase, diluted to 1:10, and then treated with streptomycin (100 µg/mL) or ciprofloxacin (1
µg/mL) and sampled over time. Error bars represent SEM (n ≥ 3). C-D. Population decay
of Syn3B P026. Syn3B P026 cells were treated with streptomycin (100 µg/mL) or
ciprofloxacin (1 µg/mL) and sampled over time. (C) Stationary phase cells were diluted
1/10 into fresh media containing antibiotics. Error bars represent SEM (n ≥ 6). (D)
Exponential phase cells were treated with streptomycin (100 µg/mL) or ciprofloxacin (1
µg/mL) and sampled over time. Error bars represent SEM (n ≥ 3). There is 100% survival
at time zero because percent survival is determined by the surviving CFU/ml compared to
the CFU/ml at time zero.
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Figure 15. Death curve comparison of Syn3B P026 by re-exposing streptomycin
and ciprofloxacin.
Overnight cultures of Syn3B were grown to stationary phase (OD~0.3-0.35), diluted to
1:10 and treated with streptomycin (100 μg/mL) or ciprofloxacin (1 μg/mL) for 48 h 904
and sampled after 24 h and 48 h. Antibiotic treated culture then washed twice through
centrifugation, grew back to stationary phase and re-exposed to same antibiotic to make
the second death curve. Error bars represent SEM (n ≥ 3).
At this point, we have demonstrated that tolerance and persistence can be detected
in Syn3B cultures during both stationary and exponential phase, and this is consistent with
native bacterial species. Another well-known phenotype of antibiotic survival is that the
tolerant population increases with co-treatment of bacteriostatic and bactericidal antibiotics
(Lewin & Smith, 1988) (pre-treatment is another method (Kwan, Valenta, Benedik, &
Wood, 2013)). To use the minimal cell as a model of antibiotic survival, this phenomenon
should also be observed. Bacteriostatic antibiotics can counteract the bactericidal
antibiotic's killing activity by arresting the growth of rapidly growing cells, which increases
tolerance to the antibiotics (Kwan et al., 2013). Chloramphenicol is a bacteriostatic
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antibiotic that inhibits translation by binding to bacterial ribosomes and inhibiting protein
synthesis, thereby inhibiting bacterial growth (Volkov, Seefeldt, & Johansson, 2019). We

Figure 16. The co-treatment of bactericidal antibiotic (streptomycin (Strep) or
ciprofloxacin (Cip) with a bacteriostatic antibiotic (chloramphenicol (Cm)) shows
increased survival of cells for 24 h (left) and 48 h (right) in Syn3B P026. Error bars
represent SEM (n ≥ 3). *p<0.05. **p<0.01.
co-treated with the bacteriostatic antibiotic chloramphenicol and either streptomycin or
ciprofloxacin. As expected, the overall percent survival with chloramphenicol co-treatment
increased compared to streptomycin or ciprofloxacin alone after 24 h and 48 h (Fig. 16).
These results support that inhibition of translation by co-treating the cell with
chloramphenicol increases tolerance in P026.
4.3.3. The minimal genome contains previously identified genes related to tolerance and
persistence.
The mechanisms of persister formation are complex, but recent studies identify
several genes involved in this process (Cameron, Shan, Zalis, Isabella, & Lewis, 2018;
Dorien Wilmaerts et al., 2019). A few of these genes are present in the minimal genome.
We identified known and predicted genes related to tolerance and persistence in the Syn3B
genome (Table 7). During nutrient limitation, bacteria generally switch their gene
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expression profile from rapid growth to a survival state by (p)ppGpp levels (a hallmark of
the stringent response), which is regulated by the RelA protein in E. coli (Boutte &
Crosson, 2013). Another important gene in the stringent response is phoU, a global
negative regulator, which is deactivated upon inorganic phosphate (Pi) starvation. Mutation
or deletion of this gene in other microorganisms leads to a metabolically hyperactive state
and decreased persistence (Y. Li & Zhang, 2007; Y. Zhang & Li, 2010). The SOS response
is another signaling pathway that upregulates DNA repair functions, which appears to be
linked to bacterial persistence. Genes related to the SOS response have been found
upregulated in E. coli persister (e.g. uvrA, uvrB) (Keren, Shah, et al., 2004), and other
mutants (such as xseB) have lost their ability to induce detectable levels of persistence
when pretreated with rifampicin, a bacteriostatic antibiotic (Cui et al., 2018).
Other literature advocates the connection of persistence with energy metabolism,
although the outcomes are often inconsistent between models (Dorien Wilmaerts et al.,
2019). For example, the deletion of atpA (encoding for ATP synthase subunit alpha)
decreases the persister fraction (Lobritz et al., 2015), but deletion of genes encoding other
parts of the ATP synthase (atpC and atpF) increases the persister fraction (Girgis, Harris,
& Tavazoie, 2012; Kiss, 2000). Several heat shock proteins, mainly proteases (e.g. lon
(Yingying Pu et al., 2016; Wu et al., 2015)) and chaperons (e.g. dnaK (Wu et al., 2015),
dnaJ (Hansen, Lewis, & Vulić, 2008), clpB (Wu et al., 2015), are related to persistence
considering that deletion of those genes decreases persistence.
Another survival mechanism connected to persistence is trans-translation, which
allows bacteria to recycle stalled ribosomes and tag unfinished polypeptides for
degradation, which in E. coli requires tmRNA (encoded by ssrA) and a small protein
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(smpB). The deletion of these genes causes persister-reduction in E.coli (S. Liu et al., 2017;
Wu et al., 2015; Yamasaki, Song, Benedik, & Wood, 2020). Additional genes (glyA (Cui
et al., 2018), galU (Girgis et al., 2012), trmE (Cui et al., 2018), efp (Cui et al., 2018), ybeY
(Cui et al., 2018), etc.; see Table 2) are indirectly related to stress response or metabolism
and have been reported to affect persistence. Overall, this shortlist (Table 2 compare to
Table S1) of genes demonstrates that there are far fewer genes to explore in the minimal
cell than any other known free-living microorganism on the planet. However, further
exploration is needed to test if there is a relationship between genes in Table 2 to antibiotic
survival in the minimal cell.
4.3.4. Evolution of the minimal cell against different types of antibiotic and wholegenome analysis of the resistant strain.
Up until this point, we have focused on antibiotic tolerance and persistence. For the
minimal system to be also useful as a model of antibiotic resistance, it must be able to
evolve resistance without horizontal gene transfer (i.e. isolated from other organisms). We
hypothesize that due to lack of complexity and less control of mutation, simpler cells likely
evolve faster than more complex organisms; a simpler, slimmed-down genome allows for
rapid evolution to selective pressures. We selected different classes of bactericidal
antibiotics including streptomycin (Strep), ciprofloxacin (Cip), a combination of
streptomycin and ciprofloxacin (Strep-Cip), and one bacteriostatic antibiotic-kasugamycin
(Ksg), to study the evolution of antibiotic resistance in the minimal genome. We applied
cyclic antibiotic treatments where we repeatedly regrew and retreated the culture with the
lethal dose of the same antibiotic for a few cycles with two biological replicates (Fig. 17B)
to make resistant mutants. In seven passes or less (nine passes with two antibiotics), the
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minimal genome rapidly evolved resistance to all antibiotics tested. We isolated single
colonies (two separate evolutionary lineages named L1 for lineage 1 or L2 for linage 2)
from each resistant mutants named Syn3B PS04 (4 Passes in Streptomycin), PC06 (6
Passes in Ciprofloxacin), PSC09 (9 Passes in Streptomycin and Ciprofloxacin), and PK07
(7 Passes in Kasugamycin). We then analyzed the whole genome for mutations. Most
mutations were in intergenic regions of the resistant mutants, similar to Syn3B P026 (Table
2).
We observed Syn3B P026 quickly evolved against streptomycin, as it only took 4
passes to become resistant. Only two non-synonymous mutations were found in both
lineages. The first one is in the rpsL gene (encoding the S12 ribosomal protein), which is
frequently identified in streptomycin-resistant strains (Villellas et al., 2013), and the other
one is the CDS_6 gene, the function of which is not yet known. In PS04_L2, we also
observed another mutation in the rpsD gene (encoding the S4 ribosomal protein). We found
that Syn3B P026 took 6 and 9 cycles to gain resistance against ciprofloxacin and a
combination of both streptomycin and ciprofloxacin, respectively. In both replicates of
PC06, we observed mutations in gyrA (encoding the DNA gyrase subunit A) and parC
(encoding DNA topoisomerase 4 subunit A). In PC06_L2, we observed another two
mutations, one in parE (encoding DNA topoisomerase 4 subunit B) and another in the
CDS_6 gene. For the combined streptomycin-ciprofloxacin resistant strains, both lineages
showed similar mutations in rpsL, gyrA, parC, and CDS_6 genes. In the kasugamycinresistant strain PK07, only two nonsynonymous mutations were found. The first one is in
the ksgA gene, which encodes a methylase that modifies 16S rRNA, and inhibition of this
protein by the antibiotic kasugamycin causes susceptibility. Therefore, when ksgA is
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inactivated, cells became kasugamycin-resistant (Mariscal et al., 2018; van Gemen, Koets,
Plooy, Bodlaender, & Van Knippenberg, 1987). We reasoned that the nonsynonymous
mutation in ksgA in PK07 makes the protein inactive and able to confer kasugamycin
resistance. The other detected non-synonymous mutation is in rpoC (RNA polymerase
subunit).
4.4. Discussion & Conclusion
Overall, we have demonstrated that the minimal cell contains both antibiotic
tolerant and persistent subpopulations, and it can quickly evolve to gain resistance. We
have successfully generated an evolved strain of the minimal cell Syn3B P026, which has
a better growth rate than the ancestral strain and overcomes one of the major difficulties of
working with the minimal cell. We show that Syn3B can be used as a model for studying
antibiotic survival, especially when we consider that the minimal genome’s core proteins
are present in many other microorganisms including human pathogens. Syn3B has over
50% similarity to human pathogens that have been identified as a concern with respect to
the growing antibiotic-resistance problem (Table 3 3) (Centers for Disease Control and
Preventions, 2019). For example, out of 455 protein-encoding genes of Syn3B, 338 of them
(74%) have homologs to S. aureus NCTC 8325 proteins. S. aureus causes meningitis and
pneumonia, and antibiotic resistance is a major problem of this organism (Foster, 2017).
The definition of persistence is often debated, but we argue that the original
definition proposed by Biggers in his seminal 1944 paper (Bigger, 1944), where persisters
were first classified and named, is sufficient. Syn3B meets 9 out of 10 characteristics
defined by Bigger. The only characteristic not found in Syn3B (point 4 in Table 8) was an
untested hypothesis that Bigger put forward about persisters, which states that persisters
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can be induced without antibiotic stress (now known as spontaneous persisters). This
characteristic has yet to be resolved and was not addressed in our work. Bigger made it
clear that persister identification should occur over several days and suggested 72 h
(Bigger, 1944). We tested Syn3B for 72 h (Fig. 14B-D), and it formed persisters. Though
we agree with Bigger's original assertion that prolonged antibiotic treatment is required to
demonstrate persistence, the originally 72 h cutoff does not consider different dividing
times of bacteria, which is likely to affect killing rates.
A more recent definition of tolerance and persistence was put forth by a consensus
statement released after a discussion panel with 121 researchers (Nathalie Q Balaban et al.,
2019). They defined persistence similarly to the original Bigger’s paper with some slight
changes. They defined persistence as a subpopulation of tolerance, and this is generally
agreed upon in the literature. They then stated that the “tolerance state” could be
distinguished from the “persistence state” based on a killing curve. We agree that persisters
can be distinguished from other populations using a kill curve (Fig. 2A), the Bigger paper
also demonstrated the importance of prolonged antibiotic treatment to identify persisters
(Bigger, 1944), and we showed that Syn3B also has a distinguished death curve (Fig. 14BD). However, we do not call the first death phase “tolerance,” as proposed by Balaban
(Nathalie Q Balaban et al., 2019), because naming this subpopulation tolerance is easily
confused when the entire population is tolerant. We, instead, label the first phase (faster
death rate) of the death curve as short-term tolerance phase contains heterogeneous
population includes susceptible cells, transient tolerant cells (caused by slow-growth or
heterogeneity in gene expression (El Meouche & Dunlop, 2018; J. J. Lee et al., 2019)),
persisters and VBNCs. Susceptible cells are included because it will take time to kill off
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these cells regardless of the antibiotic used. Transient tolerant cells can tolerate antibiotics
longer than susceptible cells, but not as long as VBNCs or persisters (VBNCs were not
investigated in this study). We termed the second phase (slower death rate) as a long-term
tolerance phase containing persister and VBNCs.
We described in our definition that a death curve can distinguish short-term tolerance and
persistence.
Few researchers have put forth that the definition for persisters should include a
rapid decline in the short-term tolerance stage and then a persister plateau (Bartell et al.,
2020; Mulcahy, Burns, Lory, & Lewis, 2010; Sahukhal, Pandey, & Elasri, 2017; Sooyeon
Song & Thomas K Wood, 2021a). Depiction of persisters as a plateau may underrepresent
the heterogeneity of the population (Kaldalu, Hauryliuk, & Tenson, 2016), and a true
plateau have a slope of zero for an extended period of time, which we do not see in our
Syn3B and E.coli data. We first tested if a plateau is present in the model organism E. coli.
Since other researchers (Aedo, Orman, & Brynildsen, 2019; Sayed Golam Mohiuddin,
Kavousi, & Orman, 2020; S. Song, Gong, Yamasaki, Kim, & Wood, 2019) and ourselves
(H. S. Deter et al., 2020) have shown that E. coli persisters can be detected after three hours
of ampicillin treatment at bactericidal concentrations (100 µg/mL treatment), we
reanalyzed our previously published data (H. S. Deter et al., 2020) and included 24
ampicillin exposure data to check for a plateau using a simple t-test point comparison. The
hypothesis is there is no plateau, the slope of the line is not zero, and a slow population
decay after 3 h. The null hypothesis is there is a plateau, the slope of the line is zero, and
the population reaches a steady-state with no decay after 3 h. Comparing the p-values of 3
h ampicillin exposure to later exposure times could test if the population is a plateau (no
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significant difference) or a slow decline (significant difference). As we suspected, the longterm E. coli death curve slope is not zero, the cells are not in a plateau, and cells are dying
slowly. This is evident by the fact that 3 h ampicillin treatment is significantly different
(p<0.05) than the longer exposures of ampicillin treatment: the p-values for 6 h, 8 h, and
24 h, were 6.5E-05, 4.6E-04, and 3.3E-06, respectively, compared to the 3 h (n≥3) (Table
5). There are points in the death curve where small plateaus (p>0.5) can be observed but
overall, no plateau. This work underscores the importance of doing long-term kill curves
as stated in recent consensus statement (Nathalie Q Balaban et al., 2019). Next, we tested
Syn3B P026 persisters and as expected, there was no plateau, the slope is not zero for
different antibiotics (Fig. 2C), and there is a slow decline in persistence over time. This is
evident by the fact that 24 h ciprofloxacin treatment was significantly different (p<0.05)
than longer exposures of ciprofloxacin treatment: the p-values for 48 h and 72 h were 5.2E05 and 3.6E-02 compared to the 24 h (n≥3). Similar results were obtained for streptomycin
(100 µg/mL); the p-value for 48 h and 72 h treatment compared to 24 h is 4.2E-3 and 3.3E2 (n≥3). Similar to E. coli, there were some points in the death curve that formed small
plateaus (p>0.5), which again underscores the importance of doing long-term kill curves.
Our results support a rapid decline in the short-term tolerance stage and then a slow decline
in the persister stage, not a plateau, which aligns with the historical data (Bigger, 1944)
and modern definition (Nathalie Q Balaban et al., 2019).
After establishing that Syn3B forms persisters, we looked into genes previously
shown to be related to tolerance in other organisms. We also find that the Syn3B genome
lacks homologs of several genes and pathways reported in earlier research to be related to
tolerance and persistence (Table 7). For instance, TA systems are often implicated for
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persistence and are still referenced as causing persistence (Moreno-del Álamo,
Marchisone, & Alonso, 2020; Riffaud, Pinel-Marie, & Felden, 2020; Shenkutie, Yao, Siu,
Wong, & Leung, 2020), although recent research provided evidence of a lack of causation
between persister formation and TA system (Conlon et al., 2016; Pontes & Groisman,
2019). In our study, we identify no known TA systems or homologous genes based on the
results from TADB 2.0 (a database designed to search for TA systems based on homology)
(Xie et al., 2018) in Syn3B. Our study clearly shows that TA systems are not required for
tolerance or persistence in the minimal cell, and it seems likely that most bacteria do not
require them either. It is not surprising that the minimal genome does not contain TA
systems because the genome was designed by researchers and not subject to the natural
environment. Natural TA systems are often described as “addictive” systems that are hard
to lose once acquired; they often have overlapping toxin and antitoxin genes, making
mutations less likely to be selected. Curiously, we observed some overlapping genes that
are not at all similar to TA systems (they are also much longer in sequence than traditional
TA systems, and are not homologous to any known TA system), and whose functions are
not yet defined (Table 4).
Recently, the Wood group (Sooyeon Song & Wood, 2020; Thomas K Wood &
Song, 2020) proposed the ppGpp ribosome dimerization persister (PRDP) model for
entering and exiting the persister state where ppGpp induces hpf, rmf, and raiA, which
converts active ribosomes into their inactive state (such as 100s ribosome) to reduce
translation, and consequently cells enter into persistence. Upon removal of antibiotic stress,
cAMP level is reduced and HflX production is stimulated, which dissociates inactive 100S
ribosomes into active 70S ribosomes and growth resumes. However, we did not detect

68
homologs to the required genes, raiA, rmf, hpf, and hflX, for ribosome dimerization in the
minimal cell genome, which means ribosome dimerization is not an essential mechanism
for this organism (or another unknown mechanism for ribosome dimerization exists in
Syn3B). (p)ppGpp may still play a role in Syn3B persistence, the genome contains relA
(converts ATP and GTP to (p)ppGpp; (Table 7). A potentially fruitful study would be to
study the effects on survival by altering (p)ppGpp of Syn3B cultures.
This strain shows that TA systems and ribosome hibernation genes are not required
for bacterial tolerance or persistence. Moreover, there are far fewer genes (less than 20
genes) present in Syn3B, which have been shown related to persistence. Thus, if specific
genes or regulons are responsible for persistence, then Syn3B should be very useful in
identifying them in future studies because it has a minimal number of genes. It is possible
that persister formation and maintenance results from slowed or disrupted cellular networks
(this is the hypothesis we most prescribe to), rather than the activity of specific genes or
regulons. If tolerance and persistence results from slowed or disrupted cellular networks,
then Syn3B is an ideal model organism to use because it has a minimal number of networks.
While different genes and networks are likely responsible for persistence depending on the
antibiotic, strain, or bacterial species, identifying genes in this minimal system should be
applicable to a number of other microorganisms including the pathogen Mycoplasma
mycoides from which Syn3B was derived. Regardless of how cells enter the dormant state,
Syn3B provides a new model to study the genes and networks that allow cells to survive
antibiotic treatment and could pave the way for finding new drugs that target the persister
and tolerant subpopulations.

69

Table 3. Comparison of % similarity (based on homologous proteins) of Syn3B with
most threatening human pathogens.
%
Homologous
similarity
Human pathogens
Related diseases
proteins No.
with
in Syn3B*
Syn3B
Escherichia coli O157
Severe intestinal infection
287
63
Pneumonia, meningitis,
osteomyelitis, endocarditis, toxic
Staphylococcus
shock syndrome, bacteremia,
338
74
aureus
sepsis, impetigo, boils, cellulitis,
folliculitis and carbuncles etc.
pneumonia in
Burkholderia cepacia
immunocompromised
262
58
individuals
Urinary tract infections,
Pseudomonas
respiratory system infections and
273
60
aeruginosa
dermatitis
Diarrhea and inflammation of the
Clostridium difficile
329
73
colon
Klebsiella
Pneumonia and infection in the
294
65
pneumoniae
lungs
Acinetobacter
Infection in the blood, urinary
272
60
baumannii
tract, and lungs (pneumonia)
Mycobacterium
Tuberculosis
275
60
tuberculosis (MTB)
Neisseria
Gonorrhea
265
58
gonorrhoeae
Pharyngitis, tonsillitis, scarlet
Streptococcus
fever, cellulitis, erysipelas and
328
72
pyogenes
rheumatic fever etc.
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Table 4. Overlapping genes in Syn3B.
Gene
Gene Length
Locus tag
name
(bp)
ieltA
ietS
CDS_33
proRS
truB
ribF
CDS_50
CDS_51
trmK;\yqfN

1062
2,274
681
1425
879
555
741
345
678

JCVISYN3A_0132
JCVISYN3A_0133
JCVISYN3A_0281
JCVISYN3A_0282
JCVSYN2_00715
JCVSYN2_00720
JCVSYN2_00955
JCVSYN2_00960
JCVSYN2_01080

CDS_60
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JCVSYN2_01085

pncB
CDS_97
CDS_124
CDS_125
CDS_99
CDS_100

1062
609
681
1539
363
1071

JCVSYN2_01655
JCVSYN2_01660
JCVSYN2_02430
JCVSYN2_02435
JCVSYN2_01695
JCVSYN2_01700

Annotation
AAA family ATPase
hypothetical protein
hypothetical protein
Proline--tRNA ligase
tRNA pseudouridine(55) synthase TruB
FAD synthetase
hypothetical protein
hypothetical protein
hypothetical protein
dinuclear metal center protein, YbgI
family
Nicotinate phosphoribosyltransferase
Uncharacterized protein
hypothetical protein
amino acid permease
lipoprotein
hypothetical protein
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Table 5. Statistical analysis between different time points of ampicillin death curve.
Escherichia coli (A), streptomycin death curve for Syn3B P026 (B) and ciprofloxacin
death curve for Syn3B P026 (C). Statistical significance was assessed using an f-test to
determine variance (p < 0.05 was considered to have significant variance), followed by a
two-tailed t-test with unequal variances (if F statistic > F critical value) or equal variances
(if F statistic < F critical value).

Time point 1

A. Ampicillin death curve of Escherichia coli
24 h p<0.05 p<0.05
p>0.05
8 h p<0.05 p>0.05
p>0.05
6 h p<0.05
p>0.05 p<0.05
3h
p<0.05
p<0.05 p<0.05
3h
6h
8h
24 h
Time point 2

Time point 1

B. Streptomycin death curve of Syn3B P026
72 h p<0.05 p>0.05
48 h p<0.05
p>0.05
24 h

p<0.05
24 h
48 h
Time point 2

p<0.05
72 h

Time point 1

C. Ciprofloxacin death curve of Syn3B P026
72 h
48 h
24 h

p<0.05
p<0.05

p>0.05

p<0.05
24 h
48 h
Time point 2

p>0.05
p<0.05
72 h

Table 6. Experimental variation in population decay curve of Syn3B P026.
Exp.
ID
1.
2.
3.
4.
5.
6.

Streptomycin
treatment for
24 h
0.03±0.0014
0.083±0.52
0.012±0.013
0.04±0.009
0.015±0.002
0.004±0.0006

Streptomycin
treatment for
48 h
0.0012±0.0003
0.008±0.067
0.006±0.002
0.002±0.00012
0.008±0.0004
0.002±0002

Ciprofloxacin
treatment for
24 h
0.09±0.0096
0.78±0.840
3.1±0.93
0.4±0.14
0.5±0.2
0.04±0.006

Ciprofloxacin
treatment for
48 h
0.003±0.0005
0.017±0.008
0.06±0.003
0.007±0.005
0.02±0.014
0.004±0006

Replicates
(n)
3
3
3
3
3
12
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Table 7. Syn3B contains genes previously shown to be related to E.coli persistence and
tolerance.
Gene

Protein/RNA

Major function

dnaK, dnaJ, clpB

Chaperon

Global regulator

phoU

Phosphate-specific transport
system accessory protein

Global regulator

xseB

Exodeoxyribonuclease

DNA mismatch repair and
recombination

REF
(Hansen et al.,
2008; Wu et al.,
2015)
(Y. Li & Zhang,
2007)
(Cui et al., 2018)

uvrA, uvrB

Endonuclease

SOS response

relA
lon

GTP pyrophosphokinase
Protease
Serine
hydroxymethyltransferase

Stringent response
Protease

(Cui et al., 2018;
Keren, Shah, et
al., 2004; Wu et
al., 2015)
(Wu et al., 2015)
(Wu et al., 2015)

Metabolism

(Cui et al., 2018)

glyA

atpA, atpC, atpF

galU
trmE; efp; ybeY

ssrA; smpB

ATP synthase

ATP synthesis

UTP--glucose-1-phosphate
uridylyltransferase
tRNA modification GTPase;
Elongation factor P;
Endoribonuclease

Lipopolysaccharide
precursor synthesis

(Girgis et al.,
2012; Kiss, 2000;
Lobritz et al.,
2015)
(Girgis et al.,
2012)

Translation

(Cui et al., 2018)

Trans-translation

(Wu et al., 2015;
Yamasaki et al.,
2020)

Transfer messenger RNA
(tmRNA); Small Protein B

73
Table 8. Comparison of Bigger’s definition of persister with characteristics of Syn3B
persisters.
1.
2.

Bigger, 1944 persister definition
An antibiotic failed to kill a small population
of bacteria.
Persisters are a small population initially
present in the population.

3.

Persister can be induced or changed based on
the environment.

4.*

Untested hypothesis: No evidence showed that
persisters were produced by the presence of an
antibiotic.
Bacteriocidal concentrations of an antibiotic
killed the susceptible population, but not
persisters.

5.

Syn3B persisters
Multiple antibiotics failed to kill a small
population of Syn3B.
Syn3B contains a small persister
subpopulation among the susceptible
population.
The persistence (surviving population) level
is different when the culture originated from
a stationary phase or exponential phase.
The persistence level is different when
cultures were co-treated with bacteriostatic
and bactericidal antibiotics compared to the
bactericidal antibiotic only; chloramphenicol
and streptomycin, and chloramphenicol and
ciprofloxacin, compared to the antibiotics
alone.
This was not tested for Syn3B persisters.

The Syn3B susceptible population was
killed by bacteriocidal concentrations of
more than one antibiotic type, but persisters
were not.
6.
Persisters are likely insensitive to an antibiotic Syn3B persisters also appear to be dormant
because they are dormant and non-dividing.
and likely non-dividing, because the
The antibiotic used, penicillin, kills bacteria
antibiotics used are more effective against
only when they divide.
dividing cells.
7.
Descendants of persisters are no more resistant Syn3B descendants of persisters are no more
to an antibiotic than the original population.
resistant to an antibiotic than the original
population.
8.
When the antibiotic is destroyed, the majority
Syn3B persisters grew once the antibiotic
of persisters will emerge and grow normally.
was removed or diluted below the MIC.
9.
The antibiotic prolongs the dormant phase but Syn3B persisters continue to die, but slowly,
not indefinitely.
the longer they are exposed to antibiotics.
There is no plateau but a slow decline in cell
death.
10.* Untested hypothesis: Persisters may be coming This was not tested for Syn3B persisters.
out of the dormant state, attempting to divide
Syn3B persisters continue to die, but slowly,
and being killed by the antibiotic.
the longer they are exposed to antibiotics.
There is no plateau but a slow decline in cell
death.
* Points 4 and 10 were untested hypotheses of Bigger and were not tested in our work.
Note: In Bigger’s 1944 paper, he identified cells that survived antibiotics longer, named them
persisters, and listed 10 characteristics of the persister subpopulation (Bigger, 1944). Syn3B meets
9 out of 10 characteristics defined by Bigger. Left column: summary of Bigger’s definition. Right
column: similar characteristics of Syn3B persisters. We provided no evidence related to point 4 but
observed a similar phenotype as Bigger to support point 10
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4.5. Limitation of the study.
We observed that despite controlling methodology to the greatest extent possible,
persister levels varied considerably (far more than observed in our previous work with E.
coli) (Heather S Deter, Abualrahi, et al., 2019) between experiments for both streptomycin
and ciprofloxacin treatments (Table 6). We hypothesize that this variability might be due
to the stochastic fluctuations (noise) in gene expression levels, which results in protein
level variations even among genetically identical cells in a similar environment (Soltani,
Vargas-Garcia, Antunes, & Singh, 2016). We expect that gene expression and protein
production to be more erratic in Syn3B compared to natural microorganisms because this
cell has a designed genome lacking many control mechanisms and did not evolve to
achieve some level of internal cellular “equilibrium” like native cells have.
We did not test for other subpopulations that have been identified during antibiotic
treatment. We did not test for Syn3B transient tolerant cells, VBNCs, or spontaneous
persisters.
4.6. Materials and Methods
4.6.1. Microbial strains and media.
Mycoplasma mycoides JCVI-Syn3B (Hutchison et al., 2016) and its derivatives
were used in this study. Syn3B was a gift from Dr. John I. Glass from J. Craig Venter
Institute, La Jolla, CA, USA. For evolution and antibiotic survival assays, cells were
cultured at 37°C in SP16 media (57.5% 2X P1, 10.0% P4, 17.0% FBS, tetracycline 0.4%
and vitamin B1 0.5%) (see Table 9 for details), which was developed based on SP4 media
(Tully et al., 1979). All cultures were plated in SP4 agarose media (0.55% agarose) for
colony counts. Note that agar is not used because it inhibits growth.
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Table 9. SP16 media composition.
Components
2XP1
Mycoplasma Broth Base
(PPLO Broth)
Tryptone
Peptone
Yeast extract solution
(autoclaved)
TC Yeastolate
(Autoclaved)
P4
D(+)-Glucose
CMRL 1066 (with LGlutamine, without Sodium
bicarbonate)
NaHCO3 (Sodium
Bicarbonate)
Penicillin G

L-Glutamine
FBS
Fetal Bovine Serum (FBS),
Heat inactivated
Tetracycline
Vit B1

SP16 media components
Final
Supplier

Cat No.

7 mg/ml

Thomas Scientific

BD 211458

20 mg/ml
10.6 mg/ml
14 mg/ml

Fisher
Fisher
Fisher

AC611841000
BP9725-500
BP9727-500

4 mg/ml

Thomas Scientific

BD 255772

0.50%
0.25X

Fisher
Thomas Scientific

Alfa Aesar A1682836
C992B09 Mfr. No. AT1101L

1.1 mg/ml

Fisher

S233-3

625 µg/ml
(~1000 U/ml)

Fisher

146 µg/ml

Fisher

MP Biomedicals
0210054380 (powder: 5001700 u/mg)
Alfa Aesar A1420118

17%

Fisher

10-438-018 Gibco 10438018

4 µg/ml
5 µg/ml

Fisher
Acros organic

BP912-100
148990100
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Figure 17. Evolution of Syn3B P026.
A. Cells were evolved in SP16 media by a serial passage from P01 to P09. From P09,
exponential cultures were repeatedly diluted 1:100 into fresh SP16 media for higher growth
yield up until the 26 passage. Then, a single colony called P026 was selected and send for
sequencing. B. Evolution of Syn3B resistant mutants through cyclic antibiotic treatment.
Stationary phase cultures of P026 were diluted 1:10 in SP16 media containing lethal doses
of different types of antibiotic (Streptomycin, Ciprofloxacin, Streptomycin-Ciprofloxacin
and Kasugamycin) for 24 h, then washed twice through centrifugation, regrew in the
similar condition and re-exposed with same antibiotic. Finally, a single colony was selected
for whole genome sequencing. C. Antibiotic survival assay was optimized based on
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traditional agar plate method. Overnight cultures were grown to stationary phase (OD>0.5),
diluted to 1:10 in antibiotic-containing media. Percent surviving cells were calculated by
the counting colony number before and after antibiotic treatment. Over 200 individual
colonies were tested for bacterial resistance, and as expected, no resistant colonies were
detected.
4.6.2. Evolution by serial passage.
Syn3B cultures were grown in 3 mL tubes at 37°C overnight in SP16 media.
Overnight exponential cultures were serially passaged after each cycle of growth by
transferring 30 µL of culture into 3 mL fresh media to initiate the next cycle of growth, and
the cycles continued until a satisfactory growth rate was observed (Fig. 17. A). The culture
was plated after 26 passages and a single colony was isolated, P026.
4.6.3. Genome extraction, whole-genome sequencing, and identification of mutations.
For whole-genome sequencing (WGS), a single colony of the evolved strains
Syn3B P026 and all the resistant mutants (PK07_L1, PK07_L2, PS04_L1, PS04_L2,
PC06_L1, PC06_L2, PSC09_L1, PSC09_L2) were isolated and inoculated into SP16
media for 24 h at 37°C. Next, genomic DNA was harvested and purified using Genomic
DNA Purification Kit (ThermoFisher) in accordance with the manufacturer’s instructions.
For quality checks, DNA purity and concentration were assessed by gel electrophoresis
and Qubit Fluorimeter prior to sending for sequencing. Novogene Ltd. sequenced the
genomes using paired-end Illumina sequencing at 2 × 150 bp read length and 350 bp insert
size. A total amount of ~1 μg of DNA per sample was used as input material for the DNA
sample preparation. Sequencing libraries were generated from the qualified DNA samples
using the NEB Next Ultra DNA Library Prep Kit for Illumina (NEB, USA) following the
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manufacturer’s protocol. For data processing, the original sequence data were transformed
into raw sequenced reads by CASAVA base calling and stored in FASTQ (fq) format. For
subsequent analysis, the raw data were filtered off the reads containing adapter and lowquality reads to obtain clean data. The resequencing analysis was based on reads mapping
to reference genome of Syn3B by BWA software (H. Li & Durbin, 2009). SAMTOOLS
(H. Li et al., 2009) was used to detect single nucleotide polymorphism (SNP) and InDels.
We also used Oxford Nanopore Technologies (ONT) MinION long-read sequencer
to search for large insertions or gene duplication in all the evolved strains. ONT libraries
were prepared using Ligation kit (SQK-LSK109) according to the manufacturer’s
instructions. R 9.5 flow cell (FLO-MIN107, ONT) was used for sequencing based on
manufacture protocol. The flow cell was mounted on a MinION Mk 1B device (ONT) for
sequencing with the MinKNOW versions 19.12.5_Sequencing_Run_FLO-MIN107_SQKLSK109 script. Then, reads were mapped against reference genome Syn3B using Geneious
Prime software version 2020.1. (https://www.geneious.com). No large insertions were
found in the sequenced genomes.
4.6.4. Minimum inhibitory concentration (MIC) tests.
Overnight cultures were serially diluted and plated onto SP4 agarose plates
containing different concentrations of antibiotics (Strep, Cip, Cm, and Ksg) to determine
the MIC of each antibiotic. Plates were incubated 4-5 days at 37°C before colony counts.
MIC values were defined in this study as the lowest antibiotic concentration that inhibit the
growth of Syn3B (See Fig. 18).
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Figure 18. Determination of Minimal Inhibitory Concentration (MIC).
A. Streptomycin (Strep) 937 B. Ciprofloxacin (Cip). C. Chloramphenicol (Cm). D.
Kasugamycin (Ksg). Exponential phase 938 cultures with different dilutions were plated
Figure 19. Determination of Minimal Inhibitory Concentration (MIC).
on SP4 agarose plate with different concentrations 939 of antibiotics. The MIC was
determined to be 10 μg/ml for streptomycin, 0.1 μg/mL for 940 ciprofloxacin, 0.5 μg/mL
Figure 20. Determination of Minimal Inhibitory Concentration (MIC).
for chloramphenicol, and 30 μg/mL for kasugamycin. Error bars 941 represent the standard
deviation and Ŧ represents data is out of detectable range.
Figure 21. Determination of Minimal Inhibitory Concentration (MIC).
4.6.5. Antibiotic survival assays.
The schematic of the antibiotic survival assay from a stationary phase culture is
shown in Fig. 17C. Briefly, an overnight culture was diluted 1:100 into pre-warmed media
and grown to exponential phase (OD600 0.1-0.3). Next, the culture was separated into three
flasks (for three biological replicates) and grown at 37˚C until it reached stationary phase
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(OD 0.45-0.55, which takes ~3-6 h). After that, each culture was diluted 1:10 into 100
µg/mL streptomycin (10X MIC) or 1 µg/mL (10X MIC) ciprofloxacin containing prewarmed media and kept at 37˚C shaking at 250 rpm for 72 h. Samples were taken at
different time points until 72 h for the time-kill assays. To remove the antibiotic before
plating, 100 μl of each sample was washed with 1.9 mL ice-cold SP16 media and collected
by centrifugation (16,000 rpm for 3 min at 4˚C). Cells were then resuspended and serially
diluted into ice-cold SP16 media and plated to count the colony-forming units (CFU).
Persisters were quantified by comparing CFUs per milliliter (CFU/ml) before antibiotic
treatment to CFU/ml after antibiotic treatment. Plates were incubated at 37ºC for 4-5 days,
then scanned using a flatbed scanner (Datla et al., 2017a; Heather S Deter, Abualrahi, et
al., 2019; Levin-Reisman et al., 2017). Custom scripts were used to identify and count
bacterial colonies (Heather S Deter, Abualrahi, et al., 2019; Heather S Deter, Dies, et al.,
2019) used to calculate CFU/ml and persister frequency. Over 200 colonies were streaked
periodically into antibiotic-containing plates to test for antibiotic-resistant mutants. Also,
antibiotic-treated culture was washed after 48 h, regrew to stationary phase, and exposed
the culture again in the same antibiotic treatment for 48 h and plated after 24 h and 48 h to
observe the difference between the first (Strep/Cip) and second death curve (Strep reexposed/Cip re-exposed) in both antibiotic treatment. Persister assay for E.coli 24 h
ampicillin treatment (unpublished data) was done by similar manner as described in REF
(H. S. Deter et al., 2020)
4.6.6. Evolution through cyclic antibiotic treatment.
Stationary phase culture was exposed to 100 μg/mL streptomycin (∼10× MIC), 1
μg/mL ciprofloxacin (∼10× MIC), a combination of streptomycin (100 μg/mL) and
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ciprofloxacin (1 μg/mL) and 300 μg/mL kasugamycin (∼10× MIC) antibiotic for 24 h, then
antibiotic-containing medium was removed by washing twice with SP16 medium (10 min
of centrifugation at 7000 g at 4°C). Finally, the culture was resuspended in 10 mL of fresh
SP16 media and grown overnight at 37 °C. After every cycle of antibiotic treatment, the
tolerance phenotype was observed (Fig. 17B). Finally, we isolated single colony from
evolved populations from streptomycin (PS04), ciprofloxacin (PC06), combination of
streptomycin and ciprofloxacin (PSC09) and kasugamycin (PK07) treatment after four, six,
nine and seven cycle, respectively, and then their genomes were sequenced. Two different
evolutionary lineages were used for all evolved populations.
4.6.7. Determination of growth and doubling times.
Overnight cultures were diluted into OD 0.1 (measured in SpectronicTM 200E) and
30 μL of diluted cultures were inoculated into individual wells containing 270 µL of SP16
media in a 96-Well Optical-Bottom Plate with Polymer Base (ThermoFisher) to measure
OD at 600 nm using FLUOstar Omega microplate reader. Doubling time was determined
by the linear regression of the natural logarithm of the OD over time during exponential
growth as described in REF (Widdel, 2007).
4.6.8. Statistical analysis.
All data is presented in the manuscript as mean ± SEM of at least three independent
biological replicates. Statistical significance was assessed using an f-test to determine
variance (p < 0.05 was considered to have significant variance), followed by a two-tailed
t-test with unequal variances (if F statistic > F critical value) or equal variances (if F statistic
< F critical value).
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4.6.9. Data and materials availability.
All data that supports the findings of this study are available from the corresponding
author upon request. Whole genomes data of P026, PK07_L1, PK07_L2, PS04_L1,
PS04_L2, PC06_L1, PC06_L2, PSC09_L1 and PSC09_L2 strains has been deposited on
the NCBI Genome Bank in BioProject PRJNA635211 with the accession number
CP053944, CP069339, CP069340, CP069341, CP069342, CP069343, CP069344,
CP069345, CP069346, respectively. The code used for colony counting is available on
GitHub at https://github.com/hdeter/CountColonies.
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5. LAYMAN’S SUMMARY
Antibiotics saved millions of lives. But bacteria rapidly evolve themselves against
antibiotics and make the antibiotics less effective. However, without having any resistant
genes, bacteria can evade antibiotic treatment using a very interesting strategy known as
antibiotic persistence. Using this mechanism bacteria go into a metabolically repressed
state and survive antibiotic treatment. For example, when we have a bacterial infection,
doctors suggest us to take antibiotic for 5-7 days. But, antibiotics kill most of the harmful
bacteria within 1-2 days and patients start to feel better. Still, patients need to continue
taking the antibiotics for several days to kill the remaining bacteria, and these bacteria are
persisters. But, these persisters can revive back after antibiotic treatment period is over and
reoccur the infection. Also, persisters are more likely to mutate, becoming antibioticresistant. Thus, it is crucial to understand the mechanism of persisters and find new
antibiotics which can target persisters. What I have done is studied when persisters form,
how persisters go into this repressed state and maintain this state for long-term antibiotic
treatment and whether a minimal cell form antibiotic persisters or not. From my study, it
is evident that some cells are prepared for stress through some transient gene expression
changes (we termed them primed cell), and these primed cells go into persister state in
response to stress. From the transcriptomic study of persister subpopulation, I have shown
that these persister bacteria uses multiple mechanisms to survive under lethal stress. In
addition, I have also shown that a minimal bacteria having only 491 genes can form
persisters. Overall, this study will help the persister researcher to get better insights about
antibiotic, provide a platform for future research, and allow us to identify key components
for the development of new drugs that target persister cells directly.
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